Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"breast: 217.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;MCF7: 1.3"	"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"					"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	217.7	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	96	"breast: 91.1;salivary gland: 31.2"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.0"	"Group enriched"	"Detected in some"	15	"breast cancer: 35.3;lung cancer: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.1	0.0	0.1	0.1	0.1	0.0	91.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	31.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MUCL1	SBEM	ENSG00000172551	"Mucin like 1"	Q96DR8	12	54830519-54858393	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	75	"breast: 283.5;salivary gland: 277.2;skin 1: 99.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 2.1;hTCEpi: 2.3;MCF7: 3.8;SK-BR-3: 9.7"	"Cancer enriched"	"Detected in many"	30	"breast cancer: 298.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"											HPA039093	Enhanced				"Secreted in other tissues"					"HPA039093: AB_10795577"	"unprognostic (2.26e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.34e-3)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"		"unprognostic (9.90e-2)"	2.9	0.0	0.1	0.1	0.1	0.0	283.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	277.2	0.1	0.2	99.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"breast: 82.6"	"Cell line enriched"	"Detected in single"	5	"U-266/70: 1.4"	"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"					"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	82.6	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SULT1C3		ENSG00000196228	"Sulfotransferase family 1C member 3"	Q6IMI6	2	108247195-108265351	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	43	"breast: 91.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;U-87 MG: 1.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"unprognostic (1.14e-3)"								"unprognostic (1.78e-1)"	"unprognostic (4.13e-1)"		"unprognostic (6.64e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	91.1	0.0	0.0	0.1	0.0			0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.2	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANKRD30A	NY-BR-1	ENSG00000148513	"Ankyrin repeat domain 30A"	Q9BXX3	10	37125788-37384111	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"breast: 31.7;testis: 17.8"	"Group enriched"	"Detected in some"	33	"A549: 3.8;U-266/70: 15.2"	"Cancer enriched"	"Detected in single"	37	"breast cancer: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071849			Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA071849: "	"unprognostic (2.79e-1)"											"unprognostic (2.81e-1)"	"unprognostic (1.01e-7)"	"unprognostic (1.41e-1)"		"unprognostic (5.93e-1)"		0.6	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397882-70410194	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"breast: 19.1;salivary gland: 59.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	36000	36000			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM1	"BUCS1, MACS1"	ENSG00000166743	"Acyl-CoA synthetase medium chain family member 1"	Q08AH1	16	20623237-20698890	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"breast: 83.4"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 18.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 14.7;prostate cancer: 36.7"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.5;memory B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA046291	Uncertain									"HPA046291: AB_10960704"	"unprognostic (1.08e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	0.0	0.1	0.0	0.0	0.0	1.1	83.4	0.1	0.1	1.7	0.4			0.2	2.3	0.2	0.1	2.4	0.2	0.1	0.0	0.0	1.2	3.8	0.2	0.1	0.0		2.8	1.4	0.5	0.0	0.0		3.4	0.2		1.2	0.2	0.1	2.2	0.4	0.3	0.0	0.2	2.1	4.5			0.2		0.1	1.1	1.5	3.4	0.0	3.5	0.9	1.3	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.9	0.1	0.0	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.1	18.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	3.5	0.1	0.2	0.1	3.4	0.6	0.0	0.0	2.9	0.5	0.2	0.0	1.3	0.0	0.0	0.0	0.1										
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 84.3;skin 1: 197.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063967	Enhanced				"Secreted in other tissues"	370000000	370000000			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				7.3	0.0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.5	1.4	0.8	1.2	1.7	1.9	0.3	0.0	1.1	0.0	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.1	0.8	0.5	0.0	0.4	1.3	0.7	0.4	0.0	0.0	0.4	1.1	3.9	0.0	0.0	0.0	1.5	0.6	0.7	1.0	0.7	0.3	0.0	0.8	1.6	1.1	0.0	1.4	0.4	0.5	0.6	0.0	1.1	0.9	0.9	0.1	0.0	0.6	0.3	0.3	1.0	0.2	5.2	1.6	2.0	1.4	1.2	2.5	1.8	1.7	1.4	1.0	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DGAT2L6	"DC3, FLJ25989"	ENSG00000184210	"Diacylglycerol O-acyltransferase 2 like 6"	Q6ZPD8	X	70177483-70205545	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"breast: 6.9;skin 1: 10.1"	"Cell line enriched"	"Detected in single"	6	"NB-4: 4.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.90e-2)"				"unprognostic (3.08e-1)"							"unprognostic (1.43e-3)"	"unprognostic (3.47e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880254	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	16	"adipose tissue: 129.9;breast: 63.7;intestine: 60.5"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 192.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2;plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018837, HPA020553"	Approved									"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	129.9	1.1	0.1	5.3	0.1	0.0	63.7	0.1	0.1	0.4	44.3	0.1	0.9	13.5	0.5	0.6	0.1	0.2	5.3	2.3	0.1	0.0	0.6	2.6	0.1	2.7	0.1	0.1	0.1	1.4	0.0	0.1	0.1	0.1	0.4	0.8	0.1	2.9	0.8	1.7	2.4	60.5	0.8	0.1	0.1	0.8	0.4	0.1	0.1	0.4	1.9	0.2	2.4	1.1	2.2	1.8	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	192.5	43.4	0.1	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	2.2	0.1	0.0	0.5	0.6	0.0	0.2	0.0	0.2	0.4	1.8	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Group enriched"	"Detected in some"	9	"BEWO: 6.8;HSkMC: 2.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010490	Approved				"Secreted to blood"	26000000	26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.2	0.4	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.2	0.4	0.1	0.3	0.1	0.0	0.2	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUSC5	"BEC-1, IFITMD3, LOST1"	ENSG00000184811	"Tumor suppressor candidate 5"	Q8IXB3	17	1279663-1300987	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"adipose tissue: 79.1;breast: 63.0"	"Cell line enriched"	"Detected in single"	262	"ASC diff: 26.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050825	Approved									"HPA050825: AB_2681252"	"unprognostic (5.84e-2)"	"unprognostic (7.21e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.10e-1)"	79.1	0.9	0.0	2.1	0.0	0.1	63.0	0.0	0.1	0.2	4.1	0.0	0.0	0.1	0.1	0.9	0.2	0.2	3.4	5.2	0.0	0.0	0.4	0.1	0.1	2.2	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	2.5	1.4	4.4	0.8	1.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.6	2.7	0.1	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664365-89679427	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 187.5;breast: 62.6"	"Cell line enriched"	"Detected in single"	176	"ASC diff: 68.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		8900	8900	Peroxisomes	Peroxisomes	"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1.0	0.4	1.1	0.0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0.0	0.7	8.0	0.3	1.5	1.5	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	68.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1.0	1.8
SLC15A5		ENSG00000188991	"Solute carrier family 15 member 5"	A6NIM6	12	16188485-16277685	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041638	Uncertain									"HPA041638: AB_2677590"	"unprognostic (3.68e-3)"				"unprognostic (1.64e-1)"								"unprognostic (4.89e-6)"		"unprognostic (1.34e-1)"	"unprognostic (1.72e-3)"		1.9	0.0	1.1	0.0	0.7	0.0	1.2	0.3	1.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	1.6		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AWAT1	DGAT2L3	ENSG00000204195	"Acyl-CoA wax alcohol acyltransferase 1"	Q58HT5	X	70234655-70240627	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 3.8;skin 1: 6.1"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063412	Enhanced									"HPA063412: AB_2685009"	"unprognostic (1.12e-1)"			"unprognostic (1.78e-1)"						"unprognostic (1.96e-2)"				"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.78e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CST9	"CLM, CTES7A"	ENSG00000173335	"Cystatin 9"	Q5W186	20	23602410-23605876	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	11	"breast: 6.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	37	"breast cancer: 9.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029190	Uncertain				"Secreted - unknown location"					"HPA029190: AB_10602804"	"unprognostic (2.06e-2)"									"unprognostic (2.21e-4)"								0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478793-34513805	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	11	"breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9"	"Group enriched"	"Detected in some"	8	"RT4: 17.4;T-47d: 33.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062706			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.1	0.0	0.0	0.0	0.1	0.0	48.8	0.0	0.0	0.5	0.0	0.0	72.2	0.6	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	6.5	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.8	0.0	1.4	0.0	0.0	85.1	86.9	0.0	3.5	0.0	1.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	3.5	1.0	5.8	1.2	0.5	0.5	2.0	1.8	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.0	0.0	0.0	3.0	0.0	33.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.0	0.3	0.2	0.5	1.8	0.3	0.2	0.3	0.4	0.3	0.5	0.4	0.4	0.9	0.7	1.8	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERHL2		ENSG00000183569	"Serine hydrolase like 2"	Q9H4I8	22	42553617-42574382	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"breast: 155.6"	"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 77.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 8.0;prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 4.1;naive B-cell: 8.9;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"B-cells: 8.9;dendritic cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.14e-1)"	"unprognostic (1.56e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	1.4	1.8	2.4	1.1	11.9	1.3	155.6	1.1	10.9	2.2	1.4	5.0	10.5	0.9	1.8	14.0	1.6	2.5	1.3	2.3	4.5	3.4	1.5	3.1	1.3	1.8	13.9	2.2	9.5	0.9	2.6	0.7	1.0	8.7	7.3	1.2	0.9	3.9	6.1	1.2	10.9	1.4	1.5	4.3	1.3	1.8	1.9	14.1	0.0	1.7	0.6	1.2	2.3	4.4	8.9	4.5	0.5	0.1	0.2	0.4	0.3	0.0	0.0	0.4	0.7	1.0	2.4	0.1	0.5	0.5	0.6	0.7	0.0	0.1	0.3	0.3	1.5	0.3	0.4	0.2	0.3	0.1	0.1	0.2	0.0	0.7	0.5	0.2	0.5	2.5	0.4	0.3	0.0	0.1	2.9	0.0	0.5	1.0	7.1	0.3	0.0	0.0	3.4	0.0	0.1	0.2	0.1	0.1	0.1	0.1	77.6	0.0	0.2	0.4	0.5	0.2	0.0	0.2	0.0	0.2	0.0	3.2	0.3	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.2	4.1	0.1	0.4	0.1	8.9	0.0	0.1	0.0	0.2	0.1	4.5	0.0	0.3	2.4	11.9	1.1	10.9	4.5	3.4	13.9	2.2	8.7	14.1
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Group enriched"	"Detected in some"	10	"Daudi: 6.9;NB-4: 6.3"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"									HPA045108	Uncertain				"Intracellular and membrane"					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"breast: 5.7;skin 1: 14.0"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 2.3;PC-3: 2.6;SK-BR-3: 1.1"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062748	Approved									"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.0;NB-4: 2.4;RPTEC TERT1: 3.6;U-2197: 1.4"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"									HPA045108	Uncertain									"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	3.6	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP4Z1	CYP4A20	ENSG00000186160	"Cytochrome P450 family 4 subfamily Z member 1"	Q86W10	1	47067488-47118319	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"breast: 23.1"	"Group enriched"	"Detected in some"	39	"HDLM-2: 13.4;SK-BR-3: 5.8"	"Cancer enriched"	"Detected in some"	50	"breast cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-3)"		"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.46e-2)"	"unprognostic (3.49e-3)"	2.5	0.2	0.4	0.4	0.9	0.0	23.1	0.4	2.0	1.0	0.4	0.4	0.4	0.0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0.0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1.0	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	2.0	0.4	1.8	0.4	0.4	0.7	0.4
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adipose tissue: 492.7;breast: 545.8"	"Group enriched"	"Detected in some"	325	"ASC diff: 275.5;RT4: 136.3"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002188, CAB024961"	Enhanced					30000000	30000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0.0	1.8	0.2	0.6	2.9	4.8	1.0	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0.0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13.0	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0.0	0.7	7.4	7.3	0.1	15.4	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	275.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0.0	0.3	0.0
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6"	"Group enriched"	"Detected in some"	6	"Hep G2: 4.5;HSkMC: 5.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.6"	"Cell type enhanced"	"Detected in many"		"NK-cell: 5.5"	"Low lineage specificity"	"Detected in many"											HPA011024	Uncertain									"HPA011024: AB_10599292"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	28.3	52.7	0.0	1.6	2.6	0.0	68.6	0.3	0.1	0.0	3.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.6	0.2	1.8	0.2	0.1	0.8	0.1	0.0	0.0	1.1	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.2	1.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.1	0.6	4.3	1.8	1.5	0.0	0.5	5.5	1.8	0.1	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.7	1.8	0.7	1.2	0.5	1.4	0.8	1.6	0.0	5.5	0.3	1.5	1.8	0.1	0.0	2.6	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.0
CIDEA	CIDE-A	ENSG00000176194	"Cell death-inducing DFFA-like effector a"	O60543	18	12254319-12277595	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 79.9;breast: 32.6"	"Cell line enriched"	"Detected in single"	8	"hTEC/SVTERT24-B: 5.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.7;cerebral cortex: 1.9;olfactory region: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 12.2"												"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	79.9	1.5	0.1	5.8	1.7	0.2	32.6	0.0	1.9	1.1	8.0	0.0	0.6	0.2	0.2	0.2	2.1	0.2	4.9	2.4	0.2	0.0	0.2	0.3	0.2	0.3	0.1	1.5	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.5	0.0	2.1	0.3	1.0	3.0	0.8	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	3.4	0.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.9	0.2	0.0	0.1	1.5	0.3	0.0
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995355-47999791	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"breast: 5.7;esophagus: 4.9;intestine: 5.0;lymphoid tissue: 2.8;skin 1: 10.3"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 18.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.0	0.0		0.0		0.0	5.7		0.0	0.0	0.0			0.0	0.0	0.0	4.9	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	10.3	5.0	0.0		0.0	0.0	0.0			0.0		2.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"		11	59086307-59094786	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	7	"blood: 4.9;breast: 12.5;lymphoid tissue: 4.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.8;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 4.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"					"Group enriched"	"Detected in some"	17	"memory B-cell: 1.9;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	24	"B-cells: 4.9"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0		1.0		0.0	12.5		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	4.1			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.6	0.0	0.0			0.0		0.0	0.0		4.9	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.2	0.0	0.3	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.5	2.5	0.2	4.9	1.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA000750: AB_1849804"	"prognostic favourable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.4	0.3	0.0	22.4	0.4	0.5	0.9	3.1	1.8	4.6	4.8	9.6	0.0	0.0	5.1	7.8	9.4	0.0	9.9	2.1	0.0	0.8	0.3	12.6	1.5	33.0	0.0	3.6	13.6	1.6	13.1	2.7	3.6	0.0	0.0	2.7	0.1	0.0	0.0	0.1	4.7	0.0	16.7	0.0	10.1	0.0	0.4	9.4	3.1	0.0	22.8	25.2	0.3	12.2	3.8	2.5	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
KRT28	KRT25D	ENSG00000173908	"Keratin 28"	Q7Z3Y7	17	40792203-40799959	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"breast: 4.6;skin 1: 14.6"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.6;endometrial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.6"	"Low region specificity"	"Detected in many"			HPA066890	Enhanced									"HPA066890: AB_2685742"																		0.6	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.8	3.7	2.4	0.9	56.0	0.5	0.0	2.3	1.2	3.7	3.4	0.9	1.8	8.0	2.5	0.7	2.1	1.4	4.5	0.4	1.5	2.4	2.2	1.8	0.1	1.1	0.0	5.5	0.4	4.3	0.6	0.8	1.0	1.0	5.1	0.4	0.0	5.6	0.2	0.3	1.1	4.6	0.4	2.6	1.0	5.1	3.4	3.5	2.0	2.3	2.1	0.6	2.9	1.8	1.0	3.2	0.4	2.0	3.8	3.1	5.9	2.5	0.2	3.4	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell line enriched"	"Detected in single"	670	"ASC diff: 84.1"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	1000000000	1000000000			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 233.9;ASC TERT1: 126.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	220000000000	220000000000	"Plasma membrane"	"Plasma membrane"	"HPA040520: AB_2677020"	"prognostic favourable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	233.9	126.0	0.3	2.0	0.5	0.0	0.0	12.9	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.4	1.4	0.0	1.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.3	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126670446	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	1.9	0.8	7.5	1.0	21.5	0.8	9.2	1.4	18.7	0.9	0.9	30.9	0.0	0.7	0.8	0.8	0.9	0.7	1.1	0.8	10.8	5.9	0.9	0.8	0.8	0.7	26.0	5.9	0.9	1.1	0.7	0.5	1.3	14.4	0.9	1.0	1.7	18.6	0.7	0.9	1.9	0.8	0.8	17.2	0.8	0.7	12.3	28.0	0.0	1.3	0.0	2.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	48.4	0.0	0.1	0.0	1.9	0.0	14.8	0.2	0.0	10.4	0.0	15.4	0.0	12.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	21.5	1.4	11.3	10.8	5.9	26.0	5.9	14.4	28.0
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 17.6;HHSteC: 7.6;HSkMC: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"									"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	Cytosol	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.5	1.5	0.2	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077105-21077963	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 1.8;bone marrow: 3.7;breast: 5.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;NB-4: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"					"Low region specificity"	"Detected in some"			CAB009386	Uncertain				"Secreted to blood"					"CAB009386: AB_2248817"	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.1	0.3	0.0	0.0	0.0	3.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 163.1;breast: 50.7;vagina: 65.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 47.8;NB-4: 9.2;RPMI-8226: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 163.1;plasmacytoid DC: 49.1"	"Group enriched"	"Detected in many"	33	"dendritic cells: 49.1;granulocytes: 163.1"									"HPA003539, CAB018374"	Uncertain									"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favourable (9.78e-4)"	"prognostic favourable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	14.9	1.2	7.8	7.7	7.8	12.1	50.7	5.0	10.1	9.7	4.6	1.5	1.5	2.4	13.8	1.5	2.8	4.2	5.6	9.2	11.1	2.4	5.4	1.5	15.9	12.3	8.5	3.9	7.6	2.6	0.6	3.7	9.3	10.9	4.4	3.1	1.5	5.6	1.5	5.7	6.8	5.4	6.1	7.6	5.3	4.2	1.5	7.9	1.5	7.0	1.5	6.4	6.8	65.4	0.7	49.1	163.1	3.2	1.1	0.0	0.7	0.1	3.9	1.5	0.5	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.5	2.7	0.0	3.8	0.0	0.0	0.0	47.8	1.6	0.2	0.7	0.1	0.0	0.3	6.6	0.0	0.0	0.0	0.0	3.1	0.1	2.5	0.0	0.6	0.2	9.2	1.2	0.2	0.5	1.7	19.5	0.0	0.5	0.2	0.1	0.2	0.1	1.1	0.5	7.3	0.1	0.2	0.6	0.2	0.1	5.2	1.4	0.4	4.3	1.1	0.0	163.1	0.4	6.7	0.0	2.4	0.0	0.2	0.0	0.0	1.1	0.7	0.0	0.0	0.3	1.1	3.2	49.1	0.0	0.7	7.8	7.8	5.0	10.1	11.1	2.4	8.5	3.9	10.9	7.9
KRTAP21-1	KAP21.1	ENSG00000187005	"Keratin associated protein 21-1"	Q3LI58	21	30754830-30755428	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"breast: 15.0;testis: 4.0"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 5.8;WM-115: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.0	0.1	0.1	0.0	15.0	0.3	0.0	0.6	0.0			0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.2	0.0	0.1	0.0		0.9	0.0		0.2	1.2	0.0	1.7	0.0	0.1	0.4	0.1	0.0	4.0			0.0		0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.8	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.2	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NLRP13	"CLR19.7, NALP13, NOD14, PAN13"	ENSG00000173572	"NLR family pyrin domain containing 13"	Q86W25	19	55891699-55932336	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"breast: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060459	Uncertain									"HPA060459: AB_2684284"												"unprognostic (2.16e-1)"			"unprognostic (4.66e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.6	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"		11000	11000	"Lipid droplets, Plasma membrane"	"Lipid droplets, Plasma membrane"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
SLCO1B7	"LST3, SLC21A21"	ENSG00000205754	"Solute carrier organic anion transporter family member 1B7 (putative)"	G3V0H7	12	21015696-21092745	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"breast: 28.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.9;A549: 4.0;CAPAN-2: 4.3;HeLa: 4.1;U-2 OS: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050892	Uncertain									"HPA050892: AB_2681265"							"unprognostic (8.82e-3)"					"unprognostic (2.53e-1)"						0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	0.0	1.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6			0.2		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.9	4.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.6	0.0	0.0	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	3.0	0.5	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006554	Enhanced				"Intracellular and membrane"					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favourable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.7	1.1	2.1	71.5	0.5	0.8	0.2	0.4	0.3	0.2	1.2	0.3	0.8	0.5	0.3	1.4	0.9	0.4	0.2	1.1	1.6	2.0	1.8	1.2	0.3	1.7	0.5	0.8	0.4	0.7	0.1	0.1	0.2	0.1	0.2	0.5	1.2	1.6	1.2	3.8	0.6	1.5	0.4	0.5	0.6	0.7	1.7	1.8	0.8	1.1	0.8	1.7	0.1	0.7	0.4	0.8	0.6	2.7	1.5	1.2	1.7	1.3	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 27.4"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 9.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"					"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.6;naive B-cell: 2.6"	"Lineage enriched"	"Detected in many"	4	"B-cells: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011126, CAB037340"	Supported				"Secreted in female reproductive system"					"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	27.4	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.6	0.0	1.0	1.6	0.0	1.3			0.0		0.6	0.1	0.0	5.6	0.0	0.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2										
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Group enriched"	"Detected in some"	5	"HSkMC: 13.3;T-47d: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	21000000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.0	2.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.3	4.3	0.0	0.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.1	33.9	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.5	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815464-31817946	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"breast: 216.1;vagina: 741.6"	"Cell line enriched"	"Detected in some"	10	"HEK 293: 302.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		77000000	77000000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	29.1	74.5	35.3	18.4	48.0	3.5	216.1	40.4	36.0	8.8	22.6	27.4	41.1	3.6	33.1	32.3	36.7	14.5	14.6	40.3	37.5	28.8	35.3	49.5	54.7	14.1	89.2	10.8	15.1	31.2	3.5	23.8	22.1	67.4	47.8	11.4	6.1	28.3	52.7	66.7	57.9	17.3	36.4	47.0	35.6	19.3	10.9	85.9	1.3	26.8	16.3	11.8	41.3	741.6	1.0	0.5	8.8	4.7	1.2	4.5	0.5	0.0	30.5	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.7	0.0	0.0	2.3	0.0	0.2	302.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	4.5	1.8	4.7	1.0	1.0	2.5	2.3	0.5	0.4	1.2	1.1	8.8	1.2	2.5	0.5	4.5	0.5	35.3	48.0	40.4	36.0	37.5	28.8	89.2	10.8	67.4	85.9
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5"	"Group enriched"	"Detected in some"	15	"HL-60: 2.8;U-937: 4.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"					"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.1	0.0	0.1	2.5	0.1	0.0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Group enriched"	"Detected in some"	10	"HaCaT: 120.2;hTCEpi: 92.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		580000000	580000000	"Intermediate filaments"	"Intermediate filaments"	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favourable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.1	0.0	0.2	0.0	120.2	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	92.9	0.2	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	10.2	0.3	0.7	0.2	0.0	0.1	1.7	0.1	2.3	0.0	2.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.6;HL-60: 19.9;NB-4: 39.2;U-937: 42.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	19.9	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	42.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0
OXTR		ENSG00000180914	"Oxytocin receptor"	P30559	3	8750408-8769628	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 42.5"	"Cell line enhanced"	"Detected in some"		"BJ: 79.3;BJ hTERT+: 24.3;BJ hTERT+ SV40 Large T+: 23.0;fHDF/TERT166: 79.4;HBF TERT88: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.18e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.24e-4)"	"unprognostic (8.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-1)"	0.5	0.4	1.8	0.3	6.5	0.6	42.5	0.9	2.2	0.5	0.3	0.1	0.0	0.3	2.8	0.5	1.1	2.7	1.0	0.6	1.8	4.0	0.6	0.4	1.0	0.4	8.6	0.8	2.8	0.3	0.3	0.3	1.3	3.7	0.9	0.3	1.6	0.4	0.9	0.3	0.4	0.4	0.6	2.5	0.5	0.3	0.5	1.2	0.1	0.4	0.0	0.4	0.4	0.0	0.0	0.2	1.6	0.1	0.1	0.3	1.0	0.2	0.8	0.4	0.1	0.1	0.2	0.1	79.3	24.3	23.0	12.3	0.1	2.1	0.0	0.1	79.4	0.1	0.3	0.1	18.0	0.7	0.4	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.1	12.8	0.0	0.1	0.6	0.5	3.5	0.1	0.3	4.7	0.8	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	1.1	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.2	0.5	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.3	1.6	0.1	0.0	0.1	0.1	1.0	1.8	6.5	0.9	2.2	1.8	4.0	8.6	0.8	3.7	1.2
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044649-107161811	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 80.2;breast: 114.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.7;Daudi: 27.0;K-562: 16.3;U-698: 69.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		1600000	1600000	Mitochondria	Mitochondria	"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (7.15e-2)"	80.2	21.5	9.4	6.0	17.2	8.4	114.1	4.5	17.0	3.9	9.1	1.9	2.4	3.1	5.1	3.9	8.4	3.4	4.7	9.0	8.8	8.6	4.5	2.4	3.2	3.0	8.4	12.1	19.5	6.5	5.6	8.1	10.7	3.0	6.4	5.5	2.6	6.8	3.9	2.2	1.6	4.7	7.4	3.4	11.1	4.1	14.5	4.6	0.8	1.6	2.8	3.3	8.4	11.8	0.2	3.1	1.3	1.5	0.5	0.1	2.5	0.0	0.4	2.5	19.7	10.6	0.0	0.0	1.0	3.2	0.8	0.7	0.0	0.0	27.0	0.2	0.6	0.0	1.9	0.0	1.5	0.7	2.2	9.0	0.0	0.0	2.9	0.1	1.2	0.1	0.0	0.0	0.0	11.9	16.3	0.8	0.0	2.0	3.7	0.1	4.8	0.7	1.0	0.0	0.0	0.0	0.0	3.2	4.7	1.4	0.3	1.0	0.6	1.9	6.7	0.9	2.6	0.0	1.9	0.6	0.0	69.4	0.7	4.7	9.4	1.3	1.5	0.0	0.0	1.4	0.1	0.2	0.0	0.0	3.1	0.0	0.1	0.1	0.7	0.5	0.7	1.1	0.0	2.5	9.4	17.2	4.5	17.0	8.8	8.6	8.4	12.1	3.0	4.6
PRSS51		ENSG00000253649	"Serine protease 51"	A0A1B0GVH4	8	10482878-10547585	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;CAPAN-2: 1.6;T-47d: 1.9;U-2 OS: 5.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted - unknown location"						"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	0.0	0.0		0.0		0.4	3.4		1.4	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	1.5	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.1	0.0	2.3			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2										
SPINK8		ENSG00000229453	"Serine peptidase inhibitor, Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"breast: 33.5"	"Cell line enriched"	"Detected in single"	62	"SK-BR-3: 40.2"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"					"Group enriched"	"Detected in some"	10	"eosinophil: 3.3;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.5"	"Region enriched"	"Detected in some"	9	"hippocampal formation: 80.7"					HPA053151	Uncertain				"Secreted to blood"					"HPA053151: AB_2682059"	"prognostic unfavourable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	1.4	0.0	1.0	7.3	33.5	0.3	0.6	0.0	0.0			0.0	0.0	1.8	4.1	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	1.5		0.0	0.2	0.0	0.2	0.0		0.4	0.0		1.8	0.1	0.0	0.2	0.0	0.0	2.3	1.2	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	40.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0										
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863563-59933655	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.1;testis: 41.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	2.2	0.5	1.3	0.9	2.3	1.4	11.1	2.5	5.7	1.3	1.2	1.0	0.8	1.1	1.1	0.9	0.8	0.8	2.0	2.1	1.2	1.2	3.3	0.8	1.6	3.1	1.8	2.7	0.4	4.9	1.3	3.0	2.9	3.9	2.9	0.8	0.6	3.0	0.7	0.8	2.0	1.7	0.6	1.6	2.3	4.5	41.7	0.8	3.0	1.9	0.2	1.5	1.3	1.0	0.9	0.1	2.6	0.3	0.0	2.7	0.5	0.1	0.5	0.1	0.5	0.2	0.3	0.6	1.6	0.4	0.7	0.1	10.2	1.0	0.0	1.6	0.7	0.2	0.2	0.0	0.4	3.2	0.2	0.1	2.0	0.1	0.0	0.1	7.6	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	4.9	21.1	1.1	0.2	0.1	0.0	0.0	0.1	0.9	2.4	0.1	1.8	37.2	5.4	1.1	33.6	1.9	0.2	0.0	1.1	4.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	2.5	0.3	2.3	2.6	0.0	2.7	0.7	1.5	1.7	0.1	0.9	0.9	1.5	2.6	0.0	0.1	0.1	1.0	0.5	1.3	2.3	2.5	5.7	1.2	1.2	1.8	2.7	3.9	0.8
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 53.4;ASC TERT1: 13.3;HSkMC: 23.2;NTERA-2: 13.3;U-87 MG: 13.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	6	"cerebellum: 100.1"						"Secreted to extracellular matrix"						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.2	0.0	53.4	13.3	6.6	0.2	2.1	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.4	0.2	8.3	0.0	0.0	23.2	0.5	1.4	0.0	0.0	0.1	4.3	0.0	0.1	0.0	0.0	13.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.6	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559434-140568805	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1"	"Group enriched"	"Detected in some"	13	"BEWO: 9.6;HAP1: 7.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	2.4	8.4	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	7.1	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.8	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.6	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1
URAD	PRHOXNB	ENSG00000183463	"Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase"	A6NGE7	13	27977714-27988654	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"breast: 8.8;intestine: 16.7"	"Group enriched"	"Detected in some"	13	"BEWO: 6.7;CACO-2: 6.1"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038972	Uncertain									"HPA038972: AB_10671869"			"unprognostic (2.00e-1)"											"unprognostic (1.05e-1)"	"unprognostic (5.21e-2)"			2.8	0.0	0.1	1.5	0.1	0.0	8.8	0.6	0.1	0.1	16.7	0.1	0.1	8.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	16.0	0.2	0.1	0.1	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ABCC11	MRP8	ENSG00000121270	"ATP binding cassette subfamily C member 11"	Q96J66	16	48166910-48247568	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 37.3"	"Cell line enriched"	"Detected in some"	4	"T-47d: 38.4"	"Group enriched"	"Detected in some"	6	"breast cancer: 8.7;prostate cancer: 2.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.6"	"Group enriched"	"Detected in many"	5	"B-cells: 2.6;T-cells: 1.2"					"Not detected"	"Not detected"			"HPA031980, HPA031981, HPA031982, CAB032513"	Approved									"CAB032513: AB_2221208, HPA031980: AB_10602303, HPA031981: AB_2674098, HPA031982: "	"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.54e-4)"	0.1	0.0	0.8	0.1	0.8	0.1	37.3	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	9.3	0.1	0.4	0.1	0.1	0.4	0.2	0.1	4.0	0.1	0.1	0.7	0.1	0.4	0.1	0.0	2.0	0.1	0.6	2.7	0.0	8.4	0.1	0.1	0.1	0.9	0.1	0.1	0.4	0.1	0.0	3.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	2.6	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	9.1	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	2.6	0.2	1.2	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.5	0.4	0.2	0.7	0.1	0.6	0.1
AC011604.2		ENSG00000257046			12	20815674-21090245	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	4	"breast: 22.5"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;A549: 2.4;CAPAN-2: 4.0;HeLa: 6.5;PC-3: 1.5;U-2 OS: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050892	Uncertain									"HPA050892: AB_2681265"						"unprognostic (2.74e-1)"	"unprognostic (1.39e-3)"					"unprognostic (3.44e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC096582.3		ENSG00000283247			7	45859994-45873082	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"breast: 2.8;epididymis: 1.2;placenta: 3.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.1	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	0.1	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	3.3	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.3	0.1	0.3	0.6	0.0	0.1	0.1	0.1	0.7	0.7	0.1	0.8	0.4	0.4	0.5	0.0	0.3	0.4	0.4	0.4	0.1	0.5	0.0	0.1	0.5	0.1	0.1	0.3	1.2	0.6	0.0	0.3	0.2	0.0	0.5	0.2	0.5	0.0	0.4	0.3	0.4	0.1	0.8	1.0	0.3	1.0	0.4	0.2	0.7	0.5	0.0	2.2	0.4	0.2	0.5	0.1	0.1	0.1	0.3	0.1	1.3	1.3	0.2	0.6	1.2	0.2	1.2	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.3	0.2	0.0										
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274790-193378843	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 17.5;salivary gland: 28.9"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.7;SK-BR-3: 5.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Region enriched"	"Detected in many"	10	"pons and medulla: 15.2"	"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031774"	Uncertain									"HPA031771: AB_2674038, HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.1	0.0	1.4	0.1	1.5	0.1	17.5	0.3	0.9	0.1	0.1	2.8	0.1	0.0	0.3	0.9	0.9	0.0	0.1	0.1	1.0	0.7	0.1	0.1	0.4	0.1	0.9	0.1	0.2	0.1	0.1	0.2	0.1	15.2	0.3	0.0	0.4	28.9	0.1	1.3	5.1	0.1	0.1	0.3	0.1	1.4	0.3	0.1	0.4	1.4	1.3	0.7	0.1	0.1	0.4	0.4	4.1	0.3	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.7	1.7	0.3	1.0	0.0	0.0	0.4	0.6	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.9	0.0	0.3	0.4	0.3	0.4	0.3	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	4.1	0.3	0.0	0.4	0.1	0.1	1.4	1.5	0.3	0.9	1.0	0.7	0.9	0.1	15.2	0.1
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931081-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 184.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.4"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"NK-cell: 1.6;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;NK-cells: 1.6"									"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"					"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			44.7	0.0	0.0	0.0	0.1	0.0	184.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.2	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.6	0.0	3.2	0.0	0.2	0.0	0.1	0.0	0.9	0.1	1.2	0.6	0.0	0.1	0.0
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779475-122784074	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 62.7;breast: 26.8"	"Group enriched"	"Detected in some"	8	"AF22: 37.8;U-251 MG: 10.2;WM-115: 22.7"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1"	"Region enriched"	"Detected in all"	6	"olfactory region: 1471.1"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favourable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavourable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13.0	0.0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32.0	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1.0	2.1	1.3	11.2	1.3	1.2	5.7	7.0	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0.0	1.1	0.0	1.1	1.4	0.0	0.4	0.2	3.1	0.3	1.1	0.4	0.0	0.0	0.0	37.8	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.4	0.0	22.7	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0.0	34.8	15.5	51.6	27.3	32.0	16.4	11.4	30.3	11.2	6.9
FAM240A		ENSG00000283473	"Family with sequence similarity 240 member A"	A0A1B0GVK7	3	46612435-46626543	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"breast: 1.9;salivary gland: 3.3"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Low region specificity"	"Detected in single"																															0.6	0.0		0.0		0.0	1.9		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.3	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		3.3	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.1			0.3		0.0	0.0		0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.5	0.4	0.8	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636914-174829314	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 6.1;pituitary gland: 12.5"	"Group enriched"	"Detected in some"	5	"HEL: 2.6;Karpas-707: 6.2;U-698: 2.2"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.5	2.6	13.3	0.6	7.3	0.6	6.1	0.7	15.2	0.5	0.5	0.3	0.0	0.5	0.7	0.5	0.5	0.4	0.6	0.4	2.7	7.4	0.5	0.4	0.5	0.9	4.6	8.7	0.4	1.4	0.5	12.5	0.5	4.4	0.5	0.5	0.0	0.5	0.5	0.4	0.7	0.5	0.8	2.1	0.6	0.5	1.7	0.0	0.0	0.5	0.0	0.9	0.4	0.2	2.7	0.1	1.1	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.6	0.0	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	2.2	0.1	0.1	0.1	0.6	0.0	0.4	0.1	0.0	0.5	2.7	0.2	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.1	0.1	0.0	13.3	7.3	0.7	14.5	2.7	7.4	4.6	8.7	4.4	0.0
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favourable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.4	17.7	0.0	10.6	0.0	12.8	0.5	3.1	3.1	3.9	13.1	0.3	0.0	1.4	2.2	0.0	10.0	0.2	3.0	0.1	2.8	0.0	0.2	14.2	3.1	0.0	4.3	3.8	0.1	0.3	0.0	0.0	0.1	0.0	3.2	0.8	0.0	0.4	17.4	0.1	2.9	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	37.7	1.7	10.7	0.0	0.0	3.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	35	"AN3-CA: 21.3;CAPAN-2: 17.8;SK-MEL-30: 62.1;WM-115: 58.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"									HPA042369	Approved				"Secreted to blood"					"HPA042369: AB_10794420"	"prognostic favourable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	62.1	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	58.8	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4
NMB	"MGC17211, MGC2277, MGC3936"	ENSG00000197696	"Neuromedin B"	P08949	15	84655129-84658563	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 37.2;brain: 28.5;breast: 59.9"	"Cell line enhanced"	"Detected in many"		"A-431: 27.5"	"Cancer enhanced"	"Detected in all"		"glioma: 93.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	16	"olfactory region: 206.6"	"Group enriched"	"Detected in many"	6	"olfactory region: 80.6;pons and medulla: 17.5"	CAB019302	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB019302: "	"unprognostic (2.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.79e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (3.81e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.36e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (7.92e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	37.2	8.0	4.6	2.8	7.5	3.3	59.9	2.4	28.5	4.0	6.5	13.7	1.0	2.3	3.1	3.2	2.5	5.0	4.5	7.0	7.0	12.2	4.4	1.9	3.8	3.6	6.6	3.5	3.4	3.3	2.7	4.2	1.4	5.6	1.9	2.1	2.6	4.6	1.8	2.0	1.8	1.4	2.9	9.9	2.0	2.5	6.4	4.8	2.2	8.9	4.9	1.9	4.7	8.5	7.0	10.4	5.9	0.8	1.3	6.4	2.6	27.5	10.5	1.9	0.4	5.5	2.4	0.2	1.7	3.3	3.7	5.1	3.7	7.6	1.2	4.4	4.4	4.9	10.6	2.1	2.1	10.3	13.3	4.2	4.1	17.1	1.4	2.8	4.6	2.5	0.8	5.8	2.2	5.4	0.0	0.4	2.0	16.1	2.6	9.3	7.8	3.0	8.3	0.0	12.2	3.5	2.2	1.0	12.0	2.7	1.6	12.5	1.8	11.0	1.3	0.7	3.7	3.5	2.6	0.2	3.0	2.6	8.5	15.9	4.4	0.0	0.8	5.9	6.3	0.6	2.3	4.9	5.0	6.4	3.5	7.0	4.8	3.6	1.2	1.3	0.3	10.4	5.6	2.6	4.6	7.5	2.4	8.5	7.0	12.2	6.6	3.5	5.6	4.8
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.4	8.2	1.7	4.4	64.1	5.7	11.0	11.1	9.0	7.0	6.2	6.9	10.5	6.2	6.6	8.3	9.4	2.5	4.6	2.1	7.9	22.7	8.5	3.6	11.1	21.0	5.8	10.8	11.2	6.0	4.7	5.4	5.7	7.2	6.3	6.2	6.1	7.8	12.9	4.9	17.6	7.6	3.7	13.8	6.8	2.4	6.3	8.4	20.6	17.6	6.4	7.5	6.8	10.2	6.3	4.9	4.1	5.0	24.3	15.0	5.2	15.8	8.4	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;CAPAN-2: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	30.4	28.0	59.8	40.9	199.5	115.1	12.2	3.2	72.1	7.8	41.8	24.1	138.2	12.8	2.6	7.6	54.4	32.9	116.8	6.9	4.3	13.6	7.2	17.8	48.2	38.6	10.0	7.8	62.6	35.4	30.4	53.6	14.8	20.0	39.2	3.1	47.6	11.3	12.0	20.7	8.1	5.3	22.1	40.2	34.2	34.1	3.7	14.4	6.4	30.5	62.7	34.2	21.6	5.9	0.7	9.3	0.7	6.7	11.0	5.8	19.8	14.3	31.3	5.0	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4
SCGB2A2	"MGB1, MGC71974, UGB2"	ENSG00000110484	"Secretoglobin family 2A member 2"	Q13296	11	62270155-62273156	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"breast: 300.8"	"Cell line enriched"	"Detected in single"	118	"SK-BR-3: 19.8"	"Cancer enriched"	"Detected in many"	23	"breast cancer: 823.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB026270	Enhanced				"Secreted in female reproductive system"					"CAB026270: AB_912980"	"unprognostic (2.38e-1)"	"unprognostic (7.28e-2)"		"prognostic favourable (9.57e-8)"						"unprognostic (4.17e-1)"				"unprognostic (3.75e-1)"				2.9	0.0	0.2	0.2	0.2	0.0	300.8	0.2	0.2	34.4	0.2	0.2	0.2	0.0	0.6	0.2	7.2	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	13.9	0.2	0.2	75.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.6	5.9	0.2	0.9	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 70.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 26.1;monocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Approved	Vesicles				Vesicles	Vesicles	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favourable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favourable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	26.5	10.5	5.2	7.4	12.2	32.2	70.3	8.5	10.3	7.6	10.2	10.5	5.9	7.4	4.6	4.0	22.7	3.7	10.4	9.8	7.4	4.5	10.1	18.4	14.1	8.7	18.5	4.6	4.2	12.8	9.1	8.6	20.2	14.9	5.8	6.7	4.4	21.1	7.4	10.4	24.8	15.1	8.1	19.0	7.0	8.9	8.1	12.5	3.3	13.2	9.9	6.7	11.2	16.0	1.7	3.6	26.1	7.6	0.9	2.4	2.5	8.3	2.9	3.5	3.7	14.9	5.7	7.3	34.2	13.6	9.4	7.1	4.6	2.9	7.0	4.7	10.7	2.8	5.5	8.3	9.6	25.3	5.4	17.8	11.4	3.1	7.4	4.0	5.8	6.3	28.9	15.8	13.5	15.7	10.6	5.3	20.9	4.5	2.9	2.8	9.5	9.6	1.2	10.2	4.0	12.2	16.7	4.4	5.9	15.0	8.1	3.5	8.7	3.5	8.7	8.3	6.6	15.4	14.8	4.8	13.3	3.3	8.9	7.4	6.4	26.1	7.6	4.4	1.2	3.7	1.0	1.7	0.9	1.4	3.6	1.2	0.8	1.3	21.0	0.9	2.7	0.9	2.4	2.5	5.2	12.2	8.5	10.3	7.4	4.5	18.5	4.6	14.9	12.5
AC136616.3		ENSG00000278782			Unmapped	1157687-1240349	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.6;breast: 4.8;cervix, uterine: 6.8;intestine: 5.2;lymphoid tissue: 7.7"	"Cell line enriched"	"Detected in single"	16	"U-251 MG: 1.6"									"Cell type enriched"	"Detected in some"	6	"naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 6.6"																																					0.0	0.0		0.1		0.4	4.8		0.0	6.8	2.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.5		1.6	0.0	0.0	0.0	5.2	0.0		2.0	0.0	0.0			0.0		7.7	3.6		6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
ACVR1C	"ACVRLK7, ALK7"	ENSG00000123612	"Activin A receptor type 1C"	Q8NER5	2	157526767-157629005	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.2;breast: 15.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 15.1;HDLM-2: 6.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6"	"HPA007982, HPA011933"	Approved				"Intracellular and membrane"					"HPA007982: AB_1078134, HPA011933: AB_1844754"	"unprognostic (1.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.12e-3)"	"unprognostic (3.62e-1)"	"unprognostic (9.31e-6)"	"unprognostic (7.28e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.30e-1)"	36.2	3.7	3.9	2.7	10.3	0.7	15.3	1.6	4.4	0.9	9.4	2.7	0.0	5.5	0.7	1.0	0.8	0.8	1.8	1.0	9.2	3.1	1.1	3.3	0.8	1.2	3.7	3.1	5.1	2.4	0.5	12.0	0.7	3.5	0.9	4.4	0.0	1.5	1.0	1.3	0.7	4.4	0.8	2.8	0.8	3.4	1.1	4.0	0.0	0.9	0.5	1.0	0.6	2.9	0.6	0.0	0.0	0.0	0.0	2.8	0.4	2.0	0.0	0.0	0.1	15.1	0.4	0.3	0.4	0.4	0.1	0.5	2.2	0.2	0.0	0.2	1.2	0.0	0.1	0.0	0.3	6.6	1.0	0.0	0.0	0.5	0.0	0.0	1.1	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	1.3	0.7	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.8	0.2	0.0	0.2	0.8	2.4	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.5	0.0	1.0	0.6	1.8	1.2	0.0	0.5	2.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	3.9	10.3	1.6	4.4	9.2	3.1	3.7	3.1	3.5	4.0
ADAMTS5	"ADAMTS11, ADMP-2"	ENSG00000154736	"ADAM metallopeptidase with thrombospondin type 1 motif 5"	Q9UNA0	21	26917912-26966513	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.2;placenta: 20.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.3;ASC TERT1: 9.9;fHDF/TERT166: 9.3;RH-30: 24.7;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA005661, CAB025996, HPA030906, HPA030908"	Approved		Supported	Nucleoplasm	"Secreted to extracellular matrix"	18000	18000	Nucleoplasm	Nucleoplasm	"CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655"	"unprognostic (1.97e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.38e-8)"	"unprognostic (1.11e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.76e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.15e-1)"	14.1	0.4	1.0	1.6	0.6	0.0	21.2	2.5	0.9	5.5	2.3	0.4	7.2	0.3	10.7	8.2	1.2	3.3	1.0	6.9	1.0	0.0	1.6	0.8	1.2	0.4	1.1	0.4	14.9	0.4	0.1	0.4	20.9	1.5	2.2	0.8	2.3	1.8	9.7	11.0	3.3	2.4	6.2	1.1	6.4	1.8	2.3	0.4	0.6	5.3	1.5	0.6	2.8	3.1	0.0	0.2	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.3	9.9	0.0	1.2	0.2	1.4	0.5	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	2.0	0.0	0.9	0.0	0.3	0.0	2.4	0.0	0.0	5.4	0.0	0.9	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.0	0.0	24.7	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.3	1.3	0.5	0.0	0.0	0.0	8.9	0.1	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.6	2.5	0.9	1.0	0.0	1.1	0.4	1.5	0.4
ADGRD2	"GPR144, PGR24"	ENSG00000180264	"Adhesion G protein-coupled receptor D2"	Q7Z7M1	9	124451425-124478589	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8"	"Cell line enriched"	"Detected in single"	15	"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7"												"unprognostic (7.39e-4)"	"unprognostic (1.34e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.23e-6)"		"unprognostic (1.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.63e-2)"		"unprognostic (2.25e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	0.0	0.6	0.1	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	7.2	0.0		0.3	0.0		0.0	5.8	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AFAP1L1	FLJ36748	ENSG00000157510	"Actin filament associated protein 1 like 1"	Q8TED9	5	149271871-149341802	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 42.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.5;HUVEC TERT2: 13.0;TIME: 18.5;WM-115: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.91e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.52e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.88e-2)"	32.1	2.4	1.1	5.6	1.3	0.2	42.9	1.2	3.1	4.2	4.4	1.0	3.5	1.3	8.4	6.2	5.8	9.0	4.3	24.6	1.3	1.2	3.9	4.6	15.2	9.8	1.3	0.7	6.6	1.1	15.2	2.4	15.4	2.8	5.6	1.2	6.6	3.4	5.8	28.3	5.2	2.9	5.1	2.9	8.3	2.4	5.8	0.4	2.9	6.9	13.7	1.9	7.3	16.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.0	1.2	0.0	0.1	7.2	1.4	24.5	0.7	3.2	3.3	5.3	0.0	2.4	0.0	1.9	1.4	0.9	0.5	3.6	2.4	0.0	0.9	0.8	0.7	0.0	3.8	0.0	0.0	5.6	0.8	2.0	9.4	13.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	3.2	0.8	0.5	0.7	3.2	0.0	8.7	0.0	0.2	18.5	1.4	5.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	43.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.1	1.3	1.2	3.1	1.3	1.2	1.3	0.7	2.8	0.4
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor, mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 41.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.92e-4)"	32.9	7.8	3.1	6.6	5.9	1.3	41.9	5.0	3.7	3.5	9.0	2.1	22.1	7.6	4.5	9.6	9.1	4.0	7.6	19.7	2.8	4.1	10.2	18.2	8.1	4.0	2.9	2.4	7.5	3.6	3.9	3.1	5.2	3.5	6.4	5.9	9.2	5.8	15.2	9.1	2.8	9.9	7.8	3.7	5.9	6.5	3.1	2.1	1.0	10.8	6.4	7.3	11.8	15.7	3.4	0.7	1.5	1.0	7.8	3.5	1.2	8.6	15.1	0.4	3.9	9.1	3.4	0.1	3.5	8.6	7.2	8.1	11.6	16.8	1.2	8.9	4.8	9.4	4.3	1.2	2.0	16.9	0.7	0.0	8.9	56.6	19.6	0.0	2.2	4.6	2.8	11.5	2.4	3.2	6.6	7.5	3.7	11.0	0.3	0.4	1.5	4.9	0.2	1.4	4.1	3.8	6.4	1.3	0.3	6.4	5.6	9.8	0.2	2.4	3.9	0.1	8.9	5.3	10.1	5.6	10.4	2.4	4.8	0.3	4.7	1.5	0.9	1.0	3.5	0.8	3.1	3.4	1.2	3.0	0.7	2.9	1.7	2.7	1.0	7.8	1.0	0.5	2.4	1.2	3.1	5.9	5.0	3.7	2.8	4.1	2.9	2.4	3.5	2.1
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.1;HDLM-2: 12.0;Hep G2: 10.5;SK-BR-3: 5.1;U-87 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (8.36e-4)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.1	0.1	0.0	0.6	0.5	0.9	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	12.0	0.0	0.1	0.1	10.5	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.2	3.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.5	5.1	0.0	0.0	0.3	0.0	0.1	0.7	0.3	0.0	0.2	0.2	0.2	6.5	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Group enriched"	"Detected in some"	4	"A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	134.6	0.1	14.2	167.1	5.7	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	3.8	0.0	0.7	0.0	0.0	0.0	0.0	38.0	251.2	0.3	0.0	0.0	14.9	8.4	0.7	0.7	0.0	5.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	76.9	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.9	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Group enriched"	"Detected in some"	5	"MCF7: 30.9;SK-BR-3: 32.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA045132	Approved									"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	30.9	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	32.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	12.7	26.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260444-44310166	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 10.5;retina: 14.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.3;BJ: 4.4;HAP1: 6.2;HEK 293: 6.3;HEL: 8.7;K-562: 4.0;SiHa: 9.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"olfactory region: 11.1"	"Region enriched"	"Detected in single"	35	"olfactory region: 27.7"	HPA001903			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	1.6	0.1	0.6	0.0	1.6	0.0	10.5	0.7	1.6	2.0	0.1	1.4	0.0	0.0	2.4	2.4	0.5	0.8	0.3	0.9	1.3	0.7	0.3	0.0	0.5	0.0	0.4	2.2	0.2	0.1	0.2	0.3	0.0	0.3	2.0	0.0	14.4	5.6	0.1	3.1	2.8	0.0	1.1	0.2	0.1	0.1	2.5	0.5	0.0	0.4	4.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.0	0.0	0.0	4.4	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	0.0	0.0	1.3	6.3	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.7	1.6	1.3	0.7	0.4	2.2	0.3	0.5
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869899-916317	"Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8"	"Group enriched"	"Detected in some"	80	"ASC diff: 21.1;BEWO: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"					"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	18.7	0.7	0.1	0.1	0.3	0.1	12.3	0.0	0.5	16.8	1.4	0.6	2.1	0.2	7.1	4.9	1.2	3.5	2.5	1.1	0.1	0.3	0.4	0.1	2.6	0.1	0.3	0.0	4.8	0.2	0.1	0.0	0.4	0.3	1.8	0.1	2.4	1.3	2.2	0.2	1.4	0.3	2.6	0.1	0.1	0.4	3.7	0.0	0.0	2.1	1.6	0.4	1.3	2.2	0.3	0.6	2.4	0.9	0.2	0.3	0.5	0.1	0.0	0.0	0.0	21.1	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.9	0.4	0.2	0.5	0.0	0.1	0.2	0.3	0.6	0.3	0.1	0.2	0.8	0.2	0.6	0.2	0.0	0.5	0.1	0.3	0.0	0.5	0.1	0.3	0.3	0.0	0.3	0.0
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5"	"Cell line enriched"	"Detected in some"	52	"ASC diff: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"																				"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	72.7	1.2	0.6	1.3	0.8	0.0	25.6	2.4	0.9	0.6	3.9	0.6	0.6	3.9	0.6	1.1	1.2	1.2	2.3	21.5	0.6	0.0	5.3	5.9	0.6	0.6	0.6	0.6	1.0	3.0	10.2	0.6	0.9	1.2	1.2	0.8	0.8	2.7	0.6	8.8	0.9	5.7	0.6	1.0	0.6	0.3	5.5	0.6	0.8	1.0	3.0	1.6	1.7	0.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.5	0.0	0.0	77.5	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.6	0.8	2.4	0.9	0.6	0.0	0.6	0.6	1.2	0.6
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARSH		ENSG00000205667	"Arylsulfatase family member H"	Q5FYA8	X	3006613-3033571	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 3.1;epididymis: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;RT4: 1.4;SK-BR-3: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-2)"	"unprognostic (8.90e-2)"		"unprognostic (6.79e-2)"		"unprognostic (2.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.63e-1)"		"unprognostic (2.65e-2)"	"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.2	0.0			0.0	0.0	3.7	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.5	0.0	0.0	0.0		0.2	0.0		0.9	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1			0.0		0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BTNL9	"BTN8, FLJ32535"	ENSG00000165810	"Butyrophilin like 9"	Q6UXG8	5	181040225-181061523	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.2;breast: 76.8"	"Cell line enriched"	"Detected in some"	6	"U-698: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.8"	"Group enriched"	"Detected in many"	6	"B-cells: 3.8;granulocytes: 1.3"	"Not detected"	"Not detected"							HPA043429			Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane"	"Nuclear membrane"	"HPA043429: "	"unprognostic (2.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (1.55e-9)"	"unprognostic (2.15e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-2)"	128.2	2.5	1.5	5.3	1.7	0.3	76.8	1.0	1.8	3.2	11.3	0.8	3.5	0.7	3.9	3.7	2.9	6.0	3.7	11.0	3.4	1.3	3.4	3.0	25.4	2.7	2.5	1.2	1.0	2.0	3.0	1.6	4.3	1.5	3.4	1.5	3.8	3.0	3.5	34.4	2.0	1.9	3.2	2.1	12.7	2.0	3.0	0.9	1.1	6.1	4.0	5.5	3.1	18.3	3.8	0.4	1.3	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.2	1.1	0.0	0.2	0.5	0.0	0.0	0.2	2.8	1.1	0.2	0.1	0.0	0.5	3.3	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	0.1	1.8	0.0	0.2	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	4.3	0.1	0.0	0.2	0.1	28.0	0.1	0.0	0.0	1.0	0.3	0.5	0.2	0.1	0.1	3.8	0.2	0.2	0.1	1.9	0.2	0.2	1.3	0.3	0.1	0.4	0.0	0.1	1.5	1.7	1.0	1.8	3.4	1.3	2.5	1.2	1.5	0.9
C6orf223	MGC45491	ENSG00000181577	"Chromosome 6 open reading frame 223"	Q8N319	6	44000580-44005958	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 23.6;lung: 9.4"	"Cell line enhanced"	"Detected in some"		"A-431: 16.8;RPTEC TERT1: 23.8;THP-1: 9.9;U-937: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA035765, HPA046117"	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA035765: AB_2797225, HPA046117: AB_10964082"	"unprognostic (2.94e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (7.06e-3)"	"unprognostic (2.34e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (9.38e-5)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.31e-1)"	0.1	0.4	1.1	1.3	0.9	0.5	23.6	0.2	3.0	0.7	1.4	0.0	0.0	1.8	0.8	4.7	0.1	0.2	6.9	2.9	1.1	0.8	4.9	1.4	9.4	2.8	0.1	1.2	0.1	2.4	0.1	0.8	0.2	0.9	0.2	0.7	3.4	3.1	0.1	0.3	0.5	3.1	0.2	0.0	0.7	0.2	0.3	0.0	1.0	2.1	1.1	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	9.9	0.0	0.0	0.2	0.3	0.0	0.1	2.0	3.5	1.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.2	3.0	1.1	0.8	0.1	1.2	0.9	0.0
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.6"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.2;U-266/70: 61.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA073649: AB_2732233"	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	12.0	2.9	22.3	1.6	31.5	1.8	40.6	8.6	23.4	4.7	4.1	3.0	0.0	6.0	7.7	2.7	5.6	9.2	4.2	3.2	13.9	11.9	10.8	8.0	17.0	2.0	17.2	12.9	3.3	2.0	31.3	2.6	8.4	13.6	2.8	4.2	17.1	17.0	3.9	1.1	13.5	5.1	5.7	3.8	2.6	11.6	2.8	9.2	0.3	12.2	0.2	1.8	5.4	7.1	0.3	0.5	0.0	0.2	4.2	0.4	0.0	3.5	3.9	3.3	0.2	2.0	0.1	5.7	0.8	4.8	1.1	0.7	2.6	6.3	0.1	3.7	4.0	3.1	2.5	0.6	0.9	0.1	5.4	0.2	10.8	10.0	1.7	0.6	0.2	1.2	0.5	1.4	1.7	13.1	0.1	4.5	3.2	8.1	0.0	2.3	2.1	13.0	0.8	11.8	13.4	5.9	8.6	3.1	2.3	7.2	9.1	42.2	14.6	1.9	21.8	13.6	0.1	0.4	1.0	61.0	23.2	7.4	0.0	5.2	4.6	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.0	0.4	0.0	4.2	0.2	0.5	0.1	0.0	22.3	31.5	8.6	23.4	13.9	11.9	17.2	12.9	13.6	9.2
CARD18	"ICEBERG, pseudo-ICE, UNQ5804"	ENSG00000255501	"Caspase recruitment domain family member 18"	P57730	11	105137721-105139726	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 8.2;skin 1: 26.7;tongue: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;EFO-21: 1.7;hTCEpi: 5.6;U-2 OS: 5.9;U-266/84: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.1"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA038582	Approved									"HPA038582: AB_10960549"		"unprognostic (3.90e-1)"				"unprognostic (2.95e-1)"			"unprognostic (1.77e-1)"					"unprognostic (2.88e-1)"	"unprognostic (3.42e-1)"			0.1	0.0	0.1	0.1	1.2	0.0	8.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.0	0.1	0.3	0.1	0.1	26.7	0.1	0.1	0.1	0.1	0.0	0.5	0.1	1.8	0.1	6.6	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	6.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CCDC178	"C18orf34, FLJ44050"	ENSG00000166960	"Coiled-coil domain containing 178"	Q5BJE1	18	32937402-33441101	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.3;breast: 18.4;testis: 16.4"	"Group enriched"	"Detected in some"	18	"HUVEC TERT2: 9.2;U-87 MG: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (1.15e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.95e-4)"	"unprognostic (4.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.94e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-3)"	"unprognostic (9.03e-3)"	23.3	0.2	0.1	0.6	0.3	0.0	18.4	0.1	0.6	7.1	3.2	0.1	3.5	0.5	2.7	3.0	2.9	1.3	2.7	1.0	0.3	0.2	3.0	0.1	2.0	1.0	0.2	0.1	4.8	0.1	0.0	0.6	0.5	0.2	8.6	0.4	0.1	0.9	2.3	3.2	0.7	0.6	1.7	0.2	9.8	0.7	16.4	0.1	0.3	1.5	0.5	0.5	3.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1
CCDC69	"DKFZP434C171, FLJ13705"	ENSG00000198624	"Coiled-coil domain containing 69"	A6NI79	5	151181052-151224145	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 99.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.2;Daudi: 52.8;U-266/70: 33.8;U-698: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043648, HPA052896"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Actin filaments"				"Plasma membrane"	"Plasma membrane"	"HPA043648: AB_10795877, HPA052896: AB_2681983"	"prognostic favourable (3.21e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	31.6	33.7	2.1	33.4	3.2	10.9	99.8	1.7	4.7	7.3	43.4	2.5	6.6	5.7	12.2	7.3	28.1	12.7	14.0	57.6	2.2	2.5	3.8	12.6	23.7	23.2	4.3	0.9	11.4	15.3	5.3	6.1	21.4	8.4	17.2	5.8	9.0	5.5	8.7	87.1	4.5	14.9	53.0	5.1	21.7	15.6	6.7	2.2	13.3	5.1	18.8	17.7	37.2	58.4	11.4	20.4	18.0	10.7	11.9	11.7	8.3	2.1	0.2	0.1	1.8	34.2	3.6	1.2	0.3	3.3	0.6	0.5	0.4	0.2	52.8	1.9	0.1	0.1	0.8	0.6	0.2	0.0	0.7	6.7	0.0	3.2	5.6	2.4	9.7	8.7	0.0	0.2	0.0	3.3	6.3	11.9	0.0	0.0	11.2	6.2	2.0	4.3	9.6	0.2	3.2	0.1	1.4	0.0	0.2	0.6	0.9	0.4	0.5	6.2	8.2	0.2	1.7	0.1	0.4	33.8	15.7	34.1	0.4	5.9	0.0	18.0	10.7	12.3	11.7	8.6	10.2	5.9	9.1	11.0	9.3	11.4	7.3	6.7	9.2	11.9	8.2	20.4	6.6	8.3	2.1	3.2	1.7	4.7	2.2	2.5	4.3	0.9	8.4	2.2
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983291-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 80.7;lymphoid tissue: 98.4"	"Cell line enriched"	"Detected in single"	52	"HUVEC TERT2: 35.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	19000000	19000000			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	56.3	5.1	0.0	5.9	0.0	0.0	80.7	0.0	0.0	37.6	8.4	0.0	16.6	0.0	37.6	11.1	20.9	9.1	17.3	27.5	0.0		8.7	34.2	26.4	39.1	0.0	0.0	12.4	0.8	2.0	6.5	0.0	0.0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0.0	98.4	0.2	15.0	0.0	1.3	17.6	16.7	6.2	25.3	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CD300LG	"CLM9, Trem4"	ENSG00000161649	"CD300 molecule like family member g"	Q6UXG3	17	43847148-43863629	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 76.1;breast: 45.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 1.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"																	870000	870000				"unprognostic (2.38e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.08e-3)"	"unprognostic (8.69e-4)"	"unprognostic (2.12e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.57e-1)"	76.1	0.9	0.1	2.8	0.2	0.0	45.4	0.1	0.5	2.2	6.1	0.1	1.2	0.0	1.7	5.4	1.5	1.8	1.7	10.5	0.1	0.0	1.9	1.4	4.6	0.5	0.1	0.2	0.8	1.1	0.2	0.1	25.2	0.2	2.6	0.1	1.4	1.7	0.8	8.2	3.1	0.9	0.3	0.1	1.1	1.0	16.0	0.1	2.1	1.2	1.7	0.2	1.5	7.8	0.5	1.6	2.4	0.2	0.6	0.2	0.1	0.1	0.0	0.1	0.3	0.0	0.0	2.0	0.3	0.0	0.6	0.2	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.4	0.3	0.4	0.0	0.5	1.0	0.4	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.6	0.4	0.3	0.1	0.6	0.3	0.4	0.1	0.1	2.4	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.2	1.6	0.5	0.2	0.2	1.2	0.6	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.2	0.1
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 80.8;HEL: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		92000000	92000000	"Golgi apparatus"	"Golgi apparatus"	"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	80.8	0.8	0.1	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	0.0	0.1	0.1	38.4	0.1	6.1	0.0	0.0	0.0	7.8	3.1	0.0	0.0	0.2	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	2.7	4.4	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.2	10.2	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691133-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 359.1;breast: 433.0;heart muscle: 347.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"		34000000	34000000	"Golgi apparatus"	"Golgi apparatus"	"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	45.7	14.1	85.8	14.4	100.5	11.1	433.0	45.7	60.9	243.9	31.8	4.5	4.5	19.9	258.4	18.3	26.1	22.2	35.2	347.0	103.4	14.7	66.4	24.6	24.5	16.6	161.0	56.6	187.4	28.9	3.3	67.0	138.7	185.5	30.5	20.6	4.5	18.1	37.7	18.9	28.0	23.8	31.1	359.1	18.5	21.7	23.3	101.3	4.5	15.2	4.5	16.1	24.7	208.8	32.7	62.6	4.3	47.1	32.1	107.1	103.6	23.8	27.4	30.6	41.4	124.2	94.2	18.4	64.0	100.3	40.2	58.6	39.5	16.8	1.6	12.5	88.7	9.3	12.2	16.1	33.4	32.4	30.8	4.6	19.1	34.3	39.4	7.3	36.5	58.5	19.9	22.0	15.5	73.3	5.7	0.0	37.9	18.7	63.6	24.9	10.0	29.9	10.8	25.6	45.2	23.2	16.4	0.1	13.5	15.4	13.8	38.4	12.2	22.8	67.6	49.6	8.4	47.3	21.5	0.1	0.0	10.4	33.2	18.3	30.9	1.8	47.1	1.5	107.1	11.6	60.4	32.7	72.6	94.6	44.6	20.2	26.8	57.1	4.3	32.1	2.6	62.6	74.3	103.6	85.8	100.5	45.7	60.9	103.4	14.7	161.0	56.6	185.5	101.3
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT/enhancer binding protein alpha"	P49715	19	33299934-33302564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 52.3;liver: 44.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 42.6;Hep G2: 22.8;NB-4: 23.5;THP-1: 85.0;U-937: 27.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.0;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	13	"dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	40.7	1.5	2.3	7.6	4.6	8.4	52.3	2.1	4.0	3.5	9.0	5.2	1.1	9.0	2.2	2.1	6.1	2.4	6.4	6.6	3.9	2.4	2.0	44.3	39.9	10.3	4.1	3.1	1.3	9.0	4.5	1.7	17.4	2.7	3.8	5.1	1.9	5.6	1.6	15.4	23.7	12.7	2.9	6.6	3.0	3.5	1.2	2.6	2.2	2.5	10.7	3.5	5.4	7.9	0.1	4.1	11.0	11.8	0.0	0.6	1.5	0.5	1.0	0.0	1.5	12.3	0.0	42.6	0.0	0.3	0.0	0.0	5.1	0.0	0.0	0.6	0.0	1.9	1.2	0.1	0.0	7.3	1.5	0.0	0.0	22.8	0.2	7.5	9.1	0.4	5.5	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	23.5	1.0	0.5	0.0	0.0	0.2	0.0	3.7	0.0	0.3	0.1	0.1	0.1	2.9	85.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	27.2	0.0	11.0	6.0	0.0	0.6	9.4	0.6	0.0	0.1	0.4	4.1	0.1	0.2	0.4	2.1	0.0	11.8	0.2	0.0	1.5	2.3	4.6	2.1	4.0	3.9	2.4	4.1	3.1	2.7	2.6
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216073	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 26.2;kidney: 48.4"	"Cell line enriched"	"Detected in some"	18	"HaCaT: 27.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Supported									"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.6	0.6	0.6	0.1	0.6	0.0	26.2	0.7	0.6	2.5	10.0	0.0	6.9	0.0	0.7	14.0	4.2	0.8	0.0	0.7	0.6	0.6	48.4	0.9	1.7	0.0	0.6	0.0	0.6	1.5	0.0	1.3	5.9	0.0	4.6	19.5	0.0	14.2	8.7	0.6	2.2	0.8	0.0	0.6	0.6	0.7	1.0	0.0	0.0	12.2	1.2	1.8	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"		16	78022515-78066761	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2"	"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.3;T-47d: 20.9"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	"Low region specificity"	"Detected in single"			HPA051511	Uncertain				"Secreted to extracellular matrix"					"HPA051511: AB_2681514"	"prognostic unfavourable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.1	0.1	0.1	1.8	0.3	0.0	14.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	4.6	0.3	0.1	1.1	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	8.6	0.0	3.3	0.1	0.0	0.1	0.1	0.1	17.1	0.1	0.1	0.8	0.1	0.0	0.0	0.1	1.9	0.0	17.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.8	0.1	1.1	0.1	0.0	0.4	0.0
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 185.2;lung: 216.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 50.0;ASC TERT1: 99.6;U-2197: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	46000000000	46000000000			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favourable (1.53e-4)"	"prognostic favourable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favourable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	70.8	11.5	6.6	16.9	8.9	0.5	185.2	5.9	10.2	17.4	20.3	4.8	39.0	8.4	15.7	54.2	17.2	6.9	38.8	72.8	8.1	6.8	20.6	7.0	216.5	8.3	8.8	7.4	5.1	6.1	2.1	5.0	37.7	13.2	7.4	10.1	17.7	9.7	19.2	26.5	27.6	16.3	90.3	10.0	65.5	8.3	24.9	1.5	2.3	15.8	40.8	5.4	28.0	24.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	50.0	99.6	0.0	6.5	10.3	0.2	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	20.1	0.0	0.2	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	8.9	5.9	10.2	8.1	6.8	8.8	7.4	13.2	1.5
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206051	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 136.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 161.0;SiHa: 95.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA009143, HPA070695"	Uncertain		Approved	Nucleoplasm	"Secreted to extracellular matrix"	4300000	4300000	Nucleoplasm	Nucleoplasm	"HPA009143: AB_1847095, HPA070695: AB_2686297"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	53.1	5.6	0.9	33.1	1.3	0.0	136.8	0.4	2.0	65.0	23.0	0.5	14.8	4.2	64.6	18.1	29.2	14.9	16.3	17.1	1.1	1.1	7.6	1.5	22.2	23.5	2.0	1.5	52.0	4.1	1.5	1.9	2.6	1.6	12.3	8.7	2.4	5.9	21.4	21.6	16.8	14.1	32.4	1.4	5.0	6.9	10.6	0.4	1.0	8.2	15.0	4.4	24.8	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	34.5	19.3	3.2	31.3	26.1	21.6	30.1	3.1	0.0	0.0	3.2	161.0	6.9	0.0	3.3	20.4	0.0	0.1	0.0	11.6	0.0	12.9	0.0	0.0	28.9	0.5	4.8	5.9	3.6	0.0	0.0	3.5	0.0	0.0	0.0	0.8	1.7	0.0	2.7	0.0	1.1	1.6	0.0	0.0	95.7	2.5	0.0	15.2	0.0	0.0	9.3	11.5	4.9	10.4	0.0	0.0	0.0	3.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.4	2.0	1.1	1.1	2.0	1.5	1.6	0.4
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573284	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"breast: 59.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.8;NTERA-2: 24.7;PC-3: 6.8;RH-30: 10.4;SCLC-21H: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	38	"plasmacytoid DC: 21.1"	"Lineage enriched"	"Detected in single"	73	"dendritic cells: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	30.9	28.9	3.8	7.7	4.4	4.0	59.8	2.1	4.3	19.0	8.4	2.7	13.4	3.5	15.1	14.7	13.1	8.6	10.8	29.1	4.7	3.9	10.6	7.1	23.8	13.4	5.6	2.5	9.8	4.5	5.1	3.5	21.7	3.9	11.7	4.0	11.6	5.4	10.5	14.5	4.8	6.8	14.6	5.0	34.1	5.9	9.2	2.5	3.6	11.2	9.1	2.7	11.2	23.9	0.0	21.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.2	3.4	0.0	0.0	1.6	0.0	0.0	0.0	24.7	6.8	0.0	10.4	0.0	1.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	21.1	0.0	0.0	3.8	4.4	2.1	4.3	4.7	3.9	5.6	2.5	3.9	2.5
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1, autophagy regulator"	Q9NTK1	10	44970981-44978810	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 204.9;breast: 227.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.4;HDLM-2: 23.9;HHSteC: 62.2;HSkMC: 48.4;HUVEC TERT2: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavourable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	204.9	14.6	8.7	14.1	16.8	2.4	227.9	10.8	19.7	14.1	36.5	2.9	10.0	7.4	25.0	14.9	23.5	25.5	28.0	37.0	8.5	6.0	13.0	48.2	70.7	20.6	9.4	3.3	51.2	107.1	4.7	12.2	33.4	21.6	25.8	5.7	12.1	16.2	13.0	81.0	19.6	9.9	30.2	39.0	9.5	12.7	31.9	11.0	0.8	33.3	13.4	19.1	52.1	27.6	0.0	3.7	1.2	0.3	0.0	0.7	1.4	6.7	0.0	0.1	0.0	34.4	16.8	1.7	0.0	2.3	0.1	0.4	0.2	2.5	0.0	0.3	3.0	0.2	0.2	2.0	0.1	23.9	0.9	0.0	0.0	2.4	62.2	0.0	0.0	48.4	0.1	0.0	0.3	38.3	0.0	14.7	0.1	0.0	0.0	0.3	0.0	0.2	1.1	0.4	5.6	0.1	2.4	1.3	0.0	0.0	0.3	1.3	0.0	1.6	0.3	1.8	1.3	0.1	1.6	0.4	0.6	0.0	10.4	0.6	0.9	0.0	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.5	0.0	0.1	3.7	0.0	1.4	8.7	16.8	10.8	19.7	8.5	6.0	9.4	3.3	21.6	11.0
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	19.7	1.5	0.1	0.0	48.8	0.0	0.2	1.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	2.2	0.1	0.4	0.1	0.0	58.4	0.2	0.3	0.4	285.8	0.3	0.2	0.0	0.0	0.1	93.6	0.5	0.2	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0
DIRC1		ENSG00000174325	"Disrupted in renal carcinoma 1"	Q969H9	2	188734155-188790104	"Disease related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 5.9;gallbladder: 2.1"	"Group enriched"	"Detected in some"	5	"ASC TERT1: 24.1;HSkMC: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA068508			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA068508: AB_2732783"	"unprognostic (3.11e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.80e-2)"			"unprognostic (2.77e-1)"		"unprognostic (2.28e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"			"unprognostic (7.39e-4)"			"unprognostic (6.95e-2)"	1.4	0.0	0.0	0.4	0.0	0.0	5.9	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	24.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRAM1	"DRAM, FLJ11259"	ENSG00000136048	"DNA damage regulated autophagy modulator 1"	Q8N682	12	101877351-102012130	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"breast: 52.5;lung: 73.9"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (8.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.19e-2)"	"prognostic favourable (6.52e-8)"	"unprognostic (1.15e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.07e-2)"	13.1	11.0	3.6	9.9	3.8	16.7	52.5	1.2	2.6	9.2	8.3	2.3	3.6	3.4	8.0	9.2	8.1	6.9	11.2	13.8	3.6	3.6	16.7	7.2	73.9	20.9	4.3	2.3	10.9	13.7	4.3	6.6	15.2	4.4	13.2	4.8	5.4	8.8	5.4	6.6	4.6	6.4	10.8	4.4	14.8	10.0	8.6	2.2	4.9	10.4	4.3	6.4	12.4	22.1	2.6	3.0	9.2	9.8	3.5	2.2	2.5	1.9	3.9	1.4	0.4	18.4	4.2	7.8	14.6	101.3	14.7	23.1	1.3	3.8	0.3	1.7	24.0	2.9	0.3	6.0	20.5	2.1	1.2	0.5	3.5	5.0	8.5	0.5	1.1	5.0	2.7	5.1	5.6	7.9	1.7	0.7	3.8	1.5	0.3	1.7	1.0	0.9	0.6	1.0	0.3	15.6	9.3	0.3	0.3	8.1	0.9	3.8	2.8	2.2	4.8	10.4	1.8	1.8	2.6	2.1	0.9	0.2	3.5	5.0	2.7	9.2	8.8	5.8	1.9	9.8	2.2	2.6	1.4	2.0	3.0	1.7	1.1	1.3	8.8	3.5	5.6	0.8	1.9	2.5	3.6	3.8	1.2	2.4	3.6	3.6	4.3	2.3	4.4	2.2
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"Early B cell factor 3"	Q9H4W6	10	129835283-129963841	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 25.8;lymphoid tissue: 29.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.9;HAP1: 11.6;LHCN-M2: 18.5;NB-4: 23.3;RH-30: 10.1;SCLC-21H: 23.9;THP-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	20.0	0.9	0.3	3.4	0.4	0.1	25.8	0.7	0.5	7.3	3.6	0.2	2.5	0.2	5.4	4.9	4.3	3.8	4.3	10.5	0.3	2.5	0.6	0.4	1.0	29.9	5.0	0.3	1.0	1.2	3.6	0.9	3.8	4.8	4.6	0.8	2.0	3.6	2.2	10.9	2.8	1.0	6.3	9.3	0.2	1.6	4.6	0.1	0.5	6.7	6.3	2.4	4.7	16.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	9.9	7.6	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	11.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	2.3	0.0	0.0	0.0	0.0	18.5	0.1	0.0	23.3	0.1	0.0	0.3	10.1	0.0	0.0	0.1	23.9	0.3	0.0	0.0	0.0	0.0	9.8	0.0	0.0	1.2	6.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.5	0.3	2.5	5.0	0.3	4.8	0.1
EFHD1	FLJ13612	ENSG00000115468	"EF-hand domain family member D1"	Q9BUP0	2	232606057-232682781	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.0;breast: 83.4;kidney: 75.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 29.7;RPTEC TERT1: 16.0;SK-BR-3: 70.9;T-47d: 55.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 100.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.1;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049331, HPA056959"	Enhanced		Supported	"Nucleoli fibrillar center,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA049331: AB_2680716, HPA056959: AB_2683288"	"unprognostic (9.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.57e-2)"	"unprognostic (9.99e-2)"	"prognostic favourable (2.93e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.29e-3)"	16.1	4.0	32.0	2.3	71.3	1.1	83.4	4.1	39.1	37.2	3.9	85.0	0.8	2.7	22.2	16.5	5.1	16.7	6.0	13.5	42.0	24.5	75.9	24.2	4.0	2.3	85.0	25.2	32.1	39.3	4.8	3.5	55.2	43.2	8.0	3.4	12.9	10.1	13.8	13.5	5.9	3.8	10.3	66.0	20.7	3.7	7.3	80.1	0.0	6.8	3.6	1.8	5.0	9.3	0.8	0.7	6.1	0.7	0.3	1.6	0.3	0.0	0.8	1.3	0.3	0.5	0.0	29.7	6.2	0.4	0.5	0.4	0.2	0.1	0.0	0.4	2.6	0.0	4.4	0.0	0.0	0.1	2.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.1	0.0	1.9	0.0	0.1	1.7	0.1	16.0	0.1	0.0	0.7	2.1	70.9	4.2	55.5	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.7	0.4	0.7	0.3	1.2	0.8	1.0	1.0	0.3	0.3	1.6	1.6	6.1	0.3	0.2	0.7	0.3	0.3	32.0	71.3	4.1	35.5	42.0	24.5	85.0	25.2	43.2	80.1
ETV3L	FLJ16478	ENSG00000253831	"ETS variant 3 like"	Q6ZN32	1	157092044-157099808	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;breast: 4.4;lymphoid tissue: 5.7"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.8;pons and medulla: 7.8"	"Group enriched"	"Detected in some"	13	"classical monocyte: 1.5;intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"					"Not detected"	"Not detected"														"unprognostic (7.39e-4)"	"unprognostic (1.53e-1)"			"unprognostic (3.22e-2)"	"unprognostic (1.79e-5)"		"unprognostic (2.25e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.57e-2)"			"unprognostic (3.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.37e-1)"		0.1	0.0	0.9	2.0	3.8	0.1	4.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.3	0.3	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.0	1.8	0.1	7.8	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.1	0.0	5.0	0.1	0.1	0.1	0.0	5.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.8	0.0	0.7	0.5	0.3	1.1	0.0	7.8	0.0
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	7	"HEL: 24.3;HMC-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favourable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.0	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.6	0.1	0.2	0.2	0.3	0.3	24.3	0.9	0.4	0.2	0.3	9.8	0.0	0.1	0.3	0.2	0.8	1.9	1.0	0.1	0.3	0.3	2.4	0.3	0.2	0.2	0.2	0.7	0.2	0.5	0.4	0.2	0.2	0.1	0.1	0.5	1.6	0.9	0.5	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2
FAM180B	LOC399888	ENSG00000196666	"Family with sequence similarity 180 member B"		11	47586693-47589194	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.6;breast: 6.9;skin 1: 5.2;thyroid gland: 3.9"	"Cell line enhanced"	"Detected in some"		"HEL: 2.2;NB-4: 2.0;SK-MEL-30: 4.1;U-937: 3.1"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"					"Cell type enriched"	"Detected in single"	5	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"					"Not detected"	"Not detected"			HPA029408	Uncertain									"HPA029408: AB_10601319"	"unprognostic (1.28e-2)"	"unprognostic (4.99e-3)"		"unprognostic (7.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	4.6	0.4	0.2	0.0	1.4	0.3	6.9	0.7	1.2	0.5	0.4			0.1	0.1	0.3	0.0	0.7	0.8	0.6	0.2	0.9	0.0	0.0	0.1	0.1	1.4		0.1	0.0	0.0	0.0	0.0		0.0	0.4		0.8	0.0	1.1	5.2	0.0	0.1	1.2	0.0	0.3	0.7			3.9		0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.2	1.3	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.3	2.2	0.4	0.7	0.0	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.5	0.2	0.2	2.0	0.1	2.0	0.3	0.2	0.6	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	4.1	0.2	0.6	1.1	0.5	0.3	0.2	0.0	0.3	0.2	0.1	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
FAM196B	C5orf57	ENSG00000204767	"Family with sequence similarity 196 member B"	A6NMK8	5	169864264-169980740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.5;breast: 14.4;salivary gland: 10.6"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 19.8;HUVEC TERT2: 12.6;U-138 MG: 32.9;U-251 MG: 11.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047227	Uncertain									"HPA047227: AB_2679992"	"unprognostic (5.30e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.92e-1)"		"unprognostic (1.26e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.73e-3)"	1.4	1.5	3.8	1.3	8.8	1.1	14.4	2.3	10.4	0.6	0.6	13.5	0.0	0.5	0.8	0.5	0.6	0.6	1.1	0.8	4.9	3.6	1.4	0.7	0.7	0.6	6.7	3.5	4.6	0.6	0.5	3.3	0.6	5.2	2.1	0.6	6.7	10.6	0.6	0.5	1.0	0.5	1.1	7.9	3.0	0.5	0.7	5.9	0.0	2.3	0.0	0.5	0.8	0.4	0.3	0.1	0.9	0.4	0.0	0.4	0.0	0.1	0.2	0.7	0.0	5.2	1.9	0.0	3.5	1.8	3.0	2.3	0.0	0.0	0.0	7.9	19.8	0.0	0.1	6.1	5.8	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.7	0.0	4.1	3.7	12.6	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	32.9	0.3	0.9	11.1	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.4	0.9	0.0	0.2	0.0	0.0	0.0	3.8	8.8	2.3	8.3	4.9	3.6	6.7	3.5	5.2	5.9
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145397-112195256	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 49.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavourable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	43.2	4.8	3.3	11.9	3.0	7.0	49.5	3.6	3.1	6.9	9.5	4.6	10.7	3.1	8.9	6.0	7.6	5.2	6.2	18.5	4.3	3.0	6.4	6.9	10.2	7.2	5.6	1.8	5.2	3.8	7.1	6.3	12.6	3.4	9.7	3.2	2.8	22.3	17.2	11.6	7.2	4.7	9.0	4.3	9.7	8.3	7.7	3.6	6.3	8.5	7.3	6.0	9.3	24.7	2.7	2.8	5.7	1.7	1.7	1.7	0.7	3.9	1.6	1.6	1.3	8.4	4.8	2.5	3.4	0.8	0.6	1.1	1.1	5.0	25.9	3.2	1.8	1.9	2.5	3.5	1.2	12.2	4.2	2.8	3.8	2.1	5.0	6.4	1.7	5.2	5.7	0.9	6.0	17.9	5.2	12.6	2.0	4.1	2.3	4.6	2.0	3.7	5.3	2.7	5.3	2.7	3.8	3.0	2.4	3.1	5.8	1.6	4.1	2.7	11.3	2.0	6.2	1.3	1.2	5.2	6.8	12.0	4.8	3.2	2.6	5.7	1.7	1.6	1.5	1.3	1.3	1.5	1.6	1.1	0.9	2.7	1.5	1.7	4.2	1.7	1.6	2.8	1.7	0.7	3.3	3.0	3.6	2.4	4.3	3.0	5.6	1.8	3.4	3.6
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.8;lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	8	"K-562: 4.6;RPMI-8226: 7.3"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			6.4	0.1	0.0	6.0	0.2	0.0	10.8	0.2	0.1	0.2	9.8	0.0	0.0	2.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	5.6	0.2	0.1	0.0	1.5	0.2	0.2	0.2	0.0	0.1	0.3	0.6	0.1	6.8	1.1	1.7	0.0	2.6	0.2	4.5	0.1	1.0	2.9	7.5	8.1	0.0	29.4	0.1	1.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.2	0.6	0.0
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689782-7695776	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 6.4;lymphoid tissue: 6.6"	"Cell line enriched"	"Detected in some"	13	"NTERA-2: 99.7"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"					"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	1.3	1.1	0.0	1.1	0.7	0.0	6.4	0.0	0.0	0.5	0.2	0.0	0.0	0.4	0.5	1.5	0.4	1.4	0.9	2.2	0.0	0.0	4.7	0.5	0.5	0.9	0.0	0.0	1.7	0.0	0.1	2.0	0.0	0.0	0.7	0.1	0.6	0.2	1.9	0.2	0.3	1.4	0.7	0.0	6.6	0.2	1.8	0.0	0.0	1.2	1.0	0.3	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	99.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923269-99929620	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.1;pancreas: 12.1;salivary gland: 9.0"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 5.7;U-2197: 4.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain									"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.0	0.5	0.1	0.0	0.3	0.0	9.1	0.0	0.5	0.0	0.1			0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	1.1	2.8	0.1	0.1	0.6		0.3	12.1	0.0	0.1	1.2		4.3	0.0		9.0	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.8	1.6			0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.6	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	1.2	2.6	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.3	0.9	0.2	2.3	0.0	0.4	0.3	0.4	0.0	0.1	0.6	1.1	1.4	1.7	0.3	1.3	0.5	1.2	3.0	0.2	0.0	1.2	0.8	0.0	1.1	0.5	0.6	0.3	1.0	5.7	1.8	0.2	0.8	0.2	1.0	4.9	0.3	0.4	1.4	0.1	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.1	0.4										
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.8;BJ hTERT+ SV40 Large T+ RasG12V: 4.1;HAP1: 6.5;SK-BR-3: 15.5;U-2197: 7.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favourable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.0	0.0	1.9	5.8	2.5	4.1	0.0	0.0	0.2	0.0	1.6	0.5	6.5	0.0	2.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.5	0.0	0.0	0.0	0.0	2.1	0.1	7.5	2.2	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1
GSC		ENSG00000133937	"Goosecoid homeobox"	P56915	14	94768216-94770230	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 11.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;HEK 293: 3.5;MCF7: 5.2;REH: 5.4;SH-SY5Y: 6.1;T-47d: 4.2;U-251 MG: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"gdTCR: 7.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.18e-10)"	"unprognostic (4.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.16e-1)"	8.5	0.2	0.1	0.3	0.1	0.1	11.6	0.1	1.5	1.7	0.9	0.0	1.5	0.5	0.5	2.3	0.9	1.0	1.1	1.9	0.1	0.3	0.4	0.1	0.2	1.1	0.2	0.0	1.5	2.1	0.3	0.7	0.1	0.6	2.4	0.2	2.8	4.8	1.8	6.2	1.5	0.2	0.1	0.1	0.1	0.8	1.7	0.2	0.1	5.1	1.7	0.9	2.0	7.9	0.0	0.1	0.4	0.1	0.2	7.1	0.4	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.1	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.3	0.0	0.5	0.7	0.1	0.0	0.1	0.9	0.4	0.2	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.2	0.0	0.6	0.2
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730843	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 13.9;parathyroid gland: 41.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.3;MCF7: 6.1;RT4: 26.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"prognostic unfavourable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	7.1	0.4	0.4	0.0	0.4	0.4	13.9	0.4	0.4	0.5	0.5	0.2	12.2	0.1	0.4	2.8	0.9	0.9	0.7	2.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.2	0.5	0.4	41.4	0.5	1.0	0.5	1.8	0.0	2.4	8.0	3.2	0.4	0.9	0.5	0.6	2.2	5.2	0.7	1.4	0.0	0.0	2.0	0.0	0.5	1.0	1.8	1.5	1.2	4.4	0.9	1.4	0.9	0.3	0.1	0.2	0.2	0.3	0.0	0.1	1.5	0.1	0.0	0.0	0.1	1.9	9.3	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.5	1.4	0.2	0.2	0.2	0.6	0.0	0.5	0.0	0.1	0.2	0.5	0.1	6.1	0.2	0.3	0.3	0.6	0.2	0.2	0.2	0.1	26.8	2.1	0.2	0.1	3.2	0.0	2.7	0.1	0.3	0.3	0.2	0.2	0.1	0.4	0.1	0.3	0.2	0.2	0.3	4.4	0.9	0.8	0.9	0.5	0.7	0.8	0.8	0.6	0.3	1.5	0.8	0.8	4.0	1.4	0.5	1.2	0.5	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	0.5	0.0
HOXC13	"HOX3, HOX3G"	ENSG00000123364	"Homeobox C13"	P31276	12	53938765-53946544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 4.4;skin 1: 13.5;tongue: 4.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.4;HaCaT: 32.4;SK-BR-3: 17.9;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051634	Enhanced									"HPA051634: AB_2616459"	"unprognostic (5.16e-3)"	"unprognostic (1.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.78e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.74e-9)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.68e-1)"	2.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	2.5	0.0	0.6	13.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	5.1	0.0	15.4	0.2	0.0	9.2	0.9	2.1	1.4	0.8	1.3	0.2	0.0	0.2	0.0	32.4	3.9	1.0	0.8	0.0	3.1	0.0	4.2	0.0	0.0	0.0	3.3	0.0	7.6	0.0	3.0	0.0	5.5	0.0	5.6	9.5	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	5.1	17.9	2.3	13.8	0.0	0.0	0.0	6.7	0.1	2.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119942	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 21.7;endometrium 1: 38.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.1;HEK 293: 25.4;RPTEC TERT1: 18.2;SCLC-21H: 7.1;SiHa: 10.6;U-251 MG: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				Nucleoplasm	Nucleoplasm	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	0.9	0.0	0.1	1.2	0.1	0.0	21.7	0.1	0.1	10.3	9.5	0.1	1.4	0.0	38.2	2.8	1.2	1.6	0.6	0.6	0.1	0.0	16.3	0.1	0.8	0.2	0.1	0.1	2.7	0.1	0.0	0.1	3.0	0.1	9.5	4.3	0.1	0.5	5.1	0.2	1.0	0.1	14.2	0.1	0.1	0.0	3.9	0.1	0.2	0.3	0.4	1.4	2.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	18.2	0.0	7.1	1.9	10.6	0.0	0.0	0.0	0.0	1.6	0.0	1.3	0.5	8.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HSPB2	"Hs.78846, MKBP"	ENSG00000170276	"Heat shock protein family B (small) member 2"	Q16082	11	111912242-111914093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.5;heart muscle: 51.6;skeletal muscle: 52.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.3;ASC TERT1: 6.1;fHDF/TERT166: 20.3;HSkMC: 7.2;LHCN-M2: 11.7;U-138 MG: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (5.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.69e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-2)"	11.5	2.5	3.1	2.8	3.6	0.8	40.5	7.8	3.7	8.4	5.8	1.4	3.9	1.7	8.2	10.6	5.4	5.3	6.3	51.6	2.8	2.5	5.0	1.2	4.7	7.5	3.8	2.5	6.0	1.3	0.8	0.8	4.2	4.0	4.8	2.5	5.1	2.5	5.3	52.6	4.4	2.4	8.5	3.0	2.2	2.9	3.6	2.0	0.0	2.7	22.0	1.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	6.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.6	7.8	3.7	2.8	2.5	3.8	2.5	4.0	2.0
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3596054-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1;breast: 36.0;salivary gland: 20.9"	"Group enriched"	"Detected in some"	4	"AF22: 7.0;REH: 28.3;U-251 MG: 11.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		5.3	0.4	2.6	0.4	2.1	1.4	36.0	6.6	1.5	0.4	0.4	2.0	6.0	0.4	0.4	1.7	0.8	0.4	0.4	1.0	3.1	3.2	13.9	0.4	8.0	0.6	4.2	1.0	0.4	0.7	0.4	0.7	0.4	16.1	0.5	0.4	2.8	20.9	1.5	0.4	6.8	0.4	0.4	5.1	0.4	0.4	0.5	1.6	3.0	0.5	0.5	0.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	28.3	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	6.6	0.2	3.1	3.2	4.2	1.0	16.1	1.6
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	39.8	0.0	2.2	1.5	23.9	2.3	1.3	2.0	1.5	4.7	0.0	0.0	0.0	4.4	13.5	0.0	9.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.2	0.9	8.1	0.0	0.0	0.0	1.4	7.7	0.0	0.0	4.4	0.0	0.0	2.5	0.0	8.9	0.0	1.5	0.0	7.8	16.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2
IRX5	IRX-2a	ENSG00000176842	"Iroquois homeobox 5"	P78411	16	54930862-54934485	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 19.0;heart muscle: 26.5"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.8;T-47d: 24.3;THP-1: 13.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 20.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7"	HPA047130			Approved	"Nuclear speckles,Microtubules,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA047130: AB_10962983"	"unprognostic (2.63e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.38e-3)"	"prognostic favourable (4.59e-4)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.28e-2)"	3.3	0.7	0.2	0.2	1.4	0.2	19.0	5.8	0.3	3.6	0.5	1.7	0.2	0.2	0.4	1.9	7.6	0.3	0.4	26.5	0.9	1.3	4.7	0.2	10.3	0.3	2.6	0.0	0.5	0.3	0.5	0.3	0.2	5.3	4.2	0.2	6.5	13.6	0.5	6.7	13.9	0.2	0.3	4.5	0.2	3.3	0.9	2.2	0.4	0.2	1.0	2.4	0.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	5.7	2.1	2.1	0.4	0.2	2.2	5.4	0.7	0.5	1.2	0.5	0.0	0.5	2.9	5.5	2.0	2.3	0.4	3.8	2.7	0.6	2.3	0.0	0.0	1.3	2.2	0.6	10.1	3.6	1.5	0.0	0.3	0.0	4.1	2.0	6.0	7.8	0.1	1.6	3.2	2.9	0.3	17.8	0.1	2.0	2.0	0.9	4.9	2.4	24.3	13.0	0.3	4.0	0.1	2.8	0.8	2.4	1.4	1.8	6.4	2.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	5.8	0.2	0.9	1.3	2.6	0.0	5.3	2.2
IRX6	"IRX-3, IRX7"	ENSG00000159387	"Iroquois homeobox 6"	P78412	16	55323760-55330760	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018332	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA018332: AB_1851920"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"		"unprognostic (4.93e-4)"	"unprognostic (2.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.46e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (3.63e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.12e-3)"	"unprognostic (5.48e-2)"	"unprognostic (5.23e-3)"	11.1	0.0	0.2	0.2	1.4	0.0	18.9	0.2	0.5	3.3	0.2	0.2	0.2	0.0	0.6	0.2	0.5	0.0	0.2	11.1	0.2	0.4	1.5	0.2	2.3	0.2	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.0	2.0	2.5	0.2	2.7	9.3	0.2	0.2	0.2	1.6	0.0	0.6	0.2	3.5	0.7	0.2	2.3	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	10.4	0.0	0.2	0.1	0.1	1.7	6.6	0.6	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in some"	13	"HEL: 47.7;HMC-1: 100.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		48000000	48000000	"Plasma membrane"	"Plasma membrane"	"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: "	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.6	0.9	2.5	3.2	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	2.1	0.0	1.1	47.7	0.0	0.0	0.0	0.0	100.2	0.0	0.0	0.0	0.0	5.6	0.6	0.1	0.0	0.0	0.2	0.4	1.3	0.0	0.1	0.0	0.0	0.0	4.7	1.2	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249431-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 31.0;lymphoid tissue: 35.1"	"Cell line enhanced"	"Detected in some"		"SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA012069	Approved					36000000	36000000			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	23.6	8.3	0.7	5.4	0.8	0.8	31.0	0.6	0.6	2.1	11.9	0.5	1.6	5.2	1.2	16.2	5.8	4.9	6.2	10.0	0.7	0.8	2.1	22.8	8.6	13.3	0.8	0.0	4.1	2.7	0.7	1.0	5.6	0.7	4.0	5.5	3.6	2.9	1.1	6.1	2.0	9.0	5.9	0.9	35.1	2.4	3.9	0.0	1.2	2.6	4.9	1.3	10.6	1.8	0.9	0.7	3.1	0.9	0.9	0.5	0.3	0.4	0.0	0.8	0.5	0.1	0.1	1.0	1.0	0.3	0.4	0.0	0.3	0.6	0.2	0.4	0.1	1.4	0.3	0.5	0.0	0.5	0.9	1.1	1.7	0.4	0.5	0.6	0.6	0.5	0.3	0.1	0.3	0.5	0.6	1.0	0.2	0.0	0.3	0.3	0.6	0.0	0.6	0.7	0.6	0.2	0.8	0.5	0.9	2.3	0.8	0.7	0.7	0.0	0.3	0.8	0.7	0.5	0.6	0.3	1.1	0.1	0.4	0.3	0.2	3.1	0.9	0.4	0.4	0.6	0.3	0.4	0.5	0.3	0.3	0.9	0.4	0.4	2.3	0.9	0.8	0.7	0.3	0.3	0.7	0.8	0.6	0.6	0.7	0.8	0.8	0.0	0.7	0.0
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 89.3"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in all"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	880000	880000	Vesicles	Vesicles	"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	89.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4
MARC1	"FLJ22390, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786759-220819657	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 71.3;breast: 81.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.0;HeLa: 21.7;Hep G2: 25.0;NTERA-2: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5"	"Group enriched"	"Detected in many"	32	"granulocytes: 28.5;monocytes: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028702	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"	71.3	3.0	4.6	7.5	6.1	7.3	81.3	3.1	4.0	3.4	7.8	2.1	18.7	3.3	1.4	5.5	3.4	2.8	6.4	6.7	3.7	4.6	3.4	33.6	4.3	4.3	4.0	3.3	2.5	4.0	4.0	3.3	9.7	4.3	14.9	6.8	4.4	27.8	10.5	4.2	1.4	3.8	2.6	2.6	4.3	3.2	0.6	1.4	0.1	22.0	2.7	1.4	3.9	7.5	0.2	0.7	28.5	20.6	0.0	0.1	4.9	5.6	3.1	2.0	0.0	0.4	0.1	51.0	0.5	0.4	0.3	0.5	16.8	0.3	0.0	2.1	0.5	0.0	10.6	1.0	0.7	0.0	10.7	0.0	21.7	25.0	1.3	0.1	0.1	2.0	0.6	0.0	0.0	0.3	1.6	0.1	0.3	5.5	0.0	10.7	21.5	9.4	0.0	0.0	0.1	2.4	6.3	6.0	14.0	3.0	3.7	0.0	14.2	12.8	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.0	20.6	8.1	0.1	1.5	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	28.5	0.0	0.4	0.2	0.0	4.9	4.6	6.1	3.1	4.0	3.7	4.6	4.0	3.3	4.3	1.4
MEST	PEG1	ENSG00000106484	"Mesoderm specific transcript"	Q5EB52	7	130486171-130506465	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.8;placenta: 193.5"	"Cell line enriched"	"Detected in many"	6	"AN3-CA: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005623			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA005623: AB_1079364"	"unprognostic (6.14e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (6.20e-5)"	"unprognostic (7.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.67e-2)"	44.9	26.0	7.8	4.7	12.9	3.4	63.8	2.6	22.7	2.4	7.5	3.4	1.1	7.9	7.3	4.6	2.6	5.2	6.6	3.7	7.9	8.0	6.7	13.7	18.8	4.1	3.3	9.0	7.8	13.0	2.5	15.4	193.5	15.5	4.1	6.1	8.4	7.0	2.5	2.2	2.1	7.2	5.3	3.2	22.4	3.0	10.1	3.3	2.0	4.3	2.5	1.9	4.5	3.7	3.1	6.7	8.6	2.0	2.7	18.8	5.3	3.1	1.7	8.3	513.1	0.1	0.0	0.0	3.5	1.6	3.6	1.7	9.8	4.8	1.5	1.1	0.1	0.4	0.1	0.0	1.4	0.0	0.0	2.7	2.6	1.6	14.1	0.1	0.0	0.2	0.1	2.7	0.0	1.3	3.0	0.0	6.9	4.4	0.3	3.4	5.2	0.8	0.0	92.3	1.0	3.9	2.9	29.2	0.0	3.0	10.0	0.0	0.3	2.3	1.3	1.2	0.0	11.5	0.2	0.1	0.3	0.0	4.4	0.0	0.4	8.6	1.9	6.2	0.7	2.0	1.7	3.1	2.0	1.4	6.7	2.8	7.6	18.8	1.1	2.7	1.2	0.3	0.1	5.3	7.8	12.9	2.6	22.7	7.9	8.0	3.3	9.0	15.5	3.3
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392613-55421992	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.1;brain: 40.5;breast: 46.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.1;HSkMC: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles				Vesicles	Vesicles	"HPA026978: AB_2672068"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favourable (3.52e-5)"	"prognostic unfavourable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.12e-2)"	61.1	6.6	33.4	7.1	40.5	5.3	46.0	2.0	23.7	2.6	5.6	4.1	1.7	5.0	3.2	4.9	3.6	1.8	4.7	5.0	26.9	7.5	3.2	6.0	4.7	9.0	11.2	5.1	1.5	1.6	0.9	2.1	13.4	4.6	3.2	6.5	3.2	2.2	4.1	2.5	2.5	4.7	5.4	6.5	8.7	2.4	7.8	5.0	1.4	3.3	1.2	5.6	5.7	4.1	4.1	3.6	9.6	1.6	2.2	4.2	15.9	5.0	12.9	19.1	3.7	32.1	25.4	9.4	3.1	1.4	2.0	2.9	2.0	15.0	7.2	9.3	1.1	0.3	5.2	4.0	4.2	9.5	1.9	2.7	0.7	23.4	8.6	2.5	0.7	58.1	1.3	2.9	3.2	2.5	0.9	5.8	4.2	0.7	7.1	1.9	5.2	3.3	2.9	12.4	2.7	5.5	1.4	1.7	18.2	1.1	2.0	2.9	4.3	4.6	2.3	5.3	6.4	4.2	3.5	2.6	1.2	10.2	7.6	2.1	4.2	9.6	1.3	1.5	1.4	1.6	4.2	3.6	1.6	2.9	3.6	4.1	2.7	2.9	3.8	2.2	1.5	1.1	1.7	15.9	33.4	40.5	2.0	16.9	26.9	7.5	11.2	5.1	4.6	5.0
MMP27		ENSG00000137675	"Matrix metallopeptidase 27"	Q9H306	11	102691487-102705806	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 10.4;tongue: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069097	Approved				"Intracellular and membrane"					"HPA069097: AB_2686085"	"unprognostic (3.99e-2)"	"unprognostic (2.37e-4)"				"unprognostic (1.25e-3)"			"unprognostic (1.63e-1)"					"unprognostic (4.60e-1)"				3.2	0.0	0.0	0.0	0.5	2.4	10.4	0.0	0.0	1.5	0.8	0.0	0.0	0.3	0.9	4.7	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	5.1	0.0	0.8	5.4	2.6	2.0	0.0	0.1	0.4	0.4	0.0	0.9	0.1	10.0	2.2	0.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRGPRX3	MRGX3	ENSG00000179826	"MAS related GPR family member X3"	Q96LB0	11	18120955-18138480	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.3;salivary gland: 7.9;tongue: 4.4"	"Cell line enriched"	"Detected in some"	10	"HBEC3-KT: 17.8"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"																				"unprognostic (1.54e-3)"	"unprognostic (5.07e-2)"			"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"		"unprognostic (7.65e-2)"	"unprognostic (1.74e-1)"					"unprognostic (4.75e-2)"	"unprognostic (2.09e-1)"			0.1	0.0	0.1	0.8	0.1	0.4	10.3	0.1	0.3	0.3	0.1	0.1	0.1	0.3	0.1	0.1	3.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	7.9	0.1	0.4	0.4	0.2	0.1	0.1	0.6	0.1	0.9	0.1	0.1	0.1	4.4	1.4	0.1	0.5	0.1	0.2	1.6	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.4	0.0	17.8	0.0	0.1	0.3	0.0	0.1	0.6	0.0	0.1	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.2	0.3	0.3	0.2	0.1	0.2	0.1	0.2	0.0	0.7	0.1	0.0	0.8	0.2	0.2	0.4	0.2	0.1	1.8	1.1	0.4	0.2	0.7	0.2	0.1	0.2	0.3	0.4	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MS4A18		ENSG00000214782	"Membrane spanning 4-domains A18"	Q3C1V0	11	60729304-60744212	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 7.8;intestine: 21.9;testis: 4.3"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045121	Approved									"HPA045121: AB_10969456"	"unprognostic (1.02e-1)"											"unprognostic (8.87e-2)"		"unprognostic (2.51e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0			21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.0	4.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841549-71844468	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 56.3"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 18.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062878			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062878: AB_2684891"	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	9.9	7.6	2.0	10.1	1.3	2.8	56.3	0.6	4.4	4.8	1.6	0.8	0.4	1.9	4.8	2.9	3.3	3.4	10.5	16.3	5.5	0.2	5.2	3.0	6.6	14.1	0.8	1.2	7.3	4.7	0.0	2.6	15.1	1.9	4.8	0.9	15.9	3.7	3.1	2.6	3.0	3.8	3.8	0.9	5.6	3.8	3.1	0.6	1.8	3.6	3.4	4.8	10.3	6.5	5.0	4.3	0.1	0.2	0.0	18.5	2.1	0.0	1.0	0.0	0.0	4.7	0.8	0.0	0.1	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.0	129.1	0.0	0.0	0.0	0.0	8.4	0.0	0.4	1.8	0.0	8.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.0	0.0	9.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	3.4	0.0	5.6	0.0	0.0	0.0	3.9	0.0	5.2	5.0	6.8	18.5	0.1	2.8	0.1	6.4	0.1	0.0	0.2	4.3	8.6	2.1	2.0	1.3	0.6	4.4	5.5	0.2	0.8	1.2	1.9	0.6
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell line enhanced"	"Detected in some"		"A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	57.8	27.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.5	0.2	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.0	0.1	0.8	0.0	12.8	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491987-84498450	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.0;esophagus: 11.0;pancreas: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 5.5;HAP1: 8.0;HEK 293: 7.0;HMC-1: 5.4;PC-3: 4.7;U-2197: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in some"			"HPA036774, CAB070169"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.2	0.0	0.3	0.2	2.2	0.0	6.0	1.0	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	11.0	0.0	0.2	0.2	0.4	1.3	0.2	0.2	0.2	0.2	2.5	0.2	0.2	10.8	0.0	0.2	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	1.3	0.2	1.5	2.1	0.2	0.2	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	8.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	4.7	0.0	2.3	0.0	0.0	0.3	1.5	0.0	0.7	0.0	0.0	0.0	0.7	0.1	0.0	2.4	8.8	2.2	0.0	0.0	0.0	1.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	1.0	1.1	0.4	1.3	2.5	0.2	0.9	0.2
NLRP8	"CLR19.2, NALP8, NOD16, PAN4"	ENSG00000179709	"NLR family pyrin domain containing 8"	Q86W28	19	55947832-55988629	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.7;breast: 1.9;heart muscle: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA056989	Uncertain									"HPA056989: AB_2683301"	"unprognostic (2.43e-2)"											"unprognostic (3.35e-1)"		"unprognostic (3.13e-1)"	"unprognostic (6.96e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.0			0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.9	0.0		0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.1	0.0	0.7	0.3	1.7	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.7	0.7	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.3	1.7	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.0	0.7	0.3	0.3	0.8	0.4	0.1	0.3	0.1	0.0										
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell line enriched"	"Detected in some"	6	"ASC diff: 59.1"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in many"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	Nucleoli	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favourable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	59.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	7.1	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2
NPY2R		ENSG00000185149	"Neuropeptide Y receptor Y2"	P49146	4	155208629-155217078	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;breast: 4.1"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;ASC diff: 3.5;HSkMC: 1.7;SH-SY5Y: 12.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 19.7"												"unprognostic (7.14e-2)"				"unprognostic (4.36e-3)"					"unprognostic (7.08e-2)"		"unprognostic (5.50e-2)"			"unprognostic (9.35e-2)"			0.8	1.1	3.4	1.3	6.9	0.1	4.1	0.1	8.6	0.4	2.7	1.8	0.0	1.1	0.2	0.4	0.2	0.5	0.2	0.7	7.3	5.5	0.3	0.1	0.2	0.2	0.8	0.0	0.4	0.1	0.1	0.2	0.2	7.8	0.5	2.8	0.2	2.0	0.2	0.1	0.5	1.5	0.6	10.2	0.6	0.3	2.5	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	6.9	0.1	8.6	7.3	5.5	0.8	0.0	7.8	0.0
NPY4R2	CH17-360D5.1	ENSG00000264717	"Neuropeptide Y receptor Y4-2"		10	47918739-47923524	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 4.2;intestine: 6.3;skin 1: 3.3"	"Cell line enriched"	"Detected in some"	11	"A549: 20.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027863	Uncertain									"HPA027863: AB_10602819"		"unprognostic (1.74e-2)"	"unprognostic (1.24e-2)"			"unprognostic (1.59e-1)"		"unprognostic (7.78e-2)"			"unprognostic (6.72e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.46e-2)"			"unprognostic (3.25e-1)"	0.2	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.4	0.0	6.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7		0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	0.0	0.0	0.0	3.3	3.4	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NWD2	KIAA1239	ENSG00000174145	"NACHT and WD repeat domain containing 2"	Q9ULI1	4	37244220-37449465	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;breast: 20.0"	"Cell line enhanced"	"Detected in single"		"AF22: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046911	Uncertain									"HPA046911: AB_2679861"	"unprognostic (1.14e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.53e-1)"		"unprognostic (5.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.26e-2)"	4.9	0.3	2.1	0.3	2.9	0.2	20.0	1.0	11.8	0.3	1.6	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	2.3	3.2	0.2	0.5	0.2	0.3	0.7	2.0	0.2	0.7	0.3	0.3	0.3	2.0	0.2	0.8	0.0	0.4	0.2	0.2	0.7	0.4	0.4	0.3	0.2	0.3	0.6	0.0	0.4	2.7	0.0	0.3	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.9	1.0	8.9	2.3	3.2	0.7	2.0	2.0	0.0
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 3.6;skin 1: 3.0;testis: 12.1"	"Cell line enhanced"	"Detected in single"		"U-266/84: 2.3"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0			0.0	1.2	2.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	12.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR1L4	"OR1L5, OR9-E"	ENSG00000136939	"Olfactory receptor family 1 subfamily L member 4"	Q8NGR5	9	122723990-122724925	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"breast: 1.1"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0			0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PDE11A		ENSG00000284741	"Phosphodiesterase 11A"		2	177628069-178108339	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"breast: 1.2;parathyroid gland: 1.5;testis: 3.6;thyroid gland: 1.6"	"Cell line enhanced"	"Detected in single"		"fHDF/TERT166: 2.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034560	Uncertain									"HPA034560: AB_10602140"																		0.0	0.0		0.0		0.0	1.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.5		0.0		0.9	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.6			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.3"	"Group enriched"	"Detected in some"	5	"AN3-CA: 48.4;BJ hTERT+: 39.2;HSkMC: 21.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"			"Nucleoli, Golgi apparatus"	"Nucleoli, Golgi apparatus"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	7.7	0.4	0.5	0.1	0.9	0.0	14.3	0.6	0.5	8.0	1.3			0.0	3.6	2.0	0.3	5.8	2.6	1.2	0.3	0.4	0.4	0.3	0.7	0.0	0.4		11.6	1.6	2.3	2.0	1.5		0.9	0.0		1.4	1.1	3.3	1.8	0.6	6.3	0.5	0.2	1.0	0.9			8.3		0.0	0.9	2.0	0.0	0.9	1.4	1.4	0.0	0.0	0.1	0.0	4.4	0.2	48.4	1.5	0.6	3.1	0.9	39.2	1.8	7.8	0.2	0.0	0.0	0.2	0.6	0.0	2.6	0.2	0.9	0.0	2.9	0.0	1.4	1.0	3.7	0.0	0.0	21.4	0.0	2.2	0.0	3.2	0.0	0.6	0.2	3.1	0.0	0.1	2.4	0.6	0.0	0.0	0.1	0.2	2.8	0.1	0.3	0.3	0.3	0.8	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1										
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;breast: 34.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;HMC-1: 9.9;RH-30: 10.7;TIME: 32.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: "	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	23.2	5.1	8.7	3.5	9.0	1.1	34.7	3.9	15.1	16.2	2.0	1.0	0.8	1.5	2.3	1.0	7.7	3.0	4.2	6.9	9.7	7.2	2.0	1.3	1.8	2.5	4.0	6.6	6.2	1.0	1.0	1.6	6.7	6.6	1.4	2.1	0.7	1.2	2.4	1.7	4.1	1.4	5.1	1.5	2.4	2.8	2.4	1.8	0.0	3.3	0.0	1.3	2.1	9.4	0.0	6.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.7	1.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	0.0	32.6	3.3	0.1	0.7	0.2	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	6.1	0.0	0.0	8.7	9.0	3.9	15.1	9.7	7.2	4.0	6.6	6.6	1.8
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell line enriched"	"Detected in some"	18	"hTCEpi: 84.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 47.4;ASC TERT1: 27.0;BEWO: 55.9;CAPAN-2: 25.0;HSkMC: 27.8;PC-3: 24.9;RT4: 34.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: "	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favourable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.6	8.6	0.0	0.0	47.4	27.0	55.9	0.9	10.4	1.3	0.5	1.8	25.0	0.0	0.0	0.9	3.9	3.4	0.1	0.2	23.2	4.8	0.0	1.9	2.3	12.6	0.0	0.0	27.8	2.3	2.3	9.0	0.1	0.0	0.0	2.0	2.4	0.0	0.1	0.1	24.9	0.0	0.0	0.0	7.1	34.1	0.0	0.2	4.0	1.5	0.5	0.0	7.7	7.8	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 33.6;ASC TERT1: 18.6;EFO-21: 12.7;HSkMC: 12.1;LHCN-M2: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA054395: AB_2682473"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.6	18.6	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.7	5.3	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	12.1	0.6	5.2	0.3	5.3	0.3	0.0	16.9	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0
PRR34	"C22orf26, FLJ10945"	ENSG00000182257	"Proline rich 34"	Q9NV39	22	46049478-46054144	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 13.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 9.0;Karpas-707: 7.6;PC-3: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (8.66e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.72e-4)"	"unprognostic (1.16e-3)"	"unprognostic (5.96e-2)"	2.7	2.0	2.2	1.8	1.8	2.0	13.2	4.4	3.1	2.2	1.7	1.7	0.0	1.9	3.0	2.2	1.0	1.4	0.7	4.1	1.9	1.5	1.9	1.3	4.2	7.1	2.6	1.1	1.8	1.4	1.9	1.9	0.8	2.2	1.6	0.6	1.4	1.8	1.2	11.7	1.4	1.4	3.2	2.3	4.0	1.7	0.9	2.0	0.2	1.3	1.8	1.0	2.6	9.7	5.0	2.4	7.4	4.0	6.2	3.5	2.1	3.9	3.7	0.0	1.0	0.6	0.2	0.0	1.2	0.3	0.4	0.1	0.0	1.2	2.2	1.8	0.8	2.1	0.6	0.6	0.0	0.0	3.2	1.3	9.0	0.0	0.1	0.0	1.3	1.1	0.1	0.5	0.6	0.4	0.0	7.6	0.4	1.8	0.4	0.0	0.0	6.1	0.2	0.5	2.3	0.3	0.0	1.6	1.2	2.2	2.1	1.7	1.1	0.7	2.3	1.3	2.7	1.0	1.9	4.9	2.3	0.4	2.4	0.0	0.8	3.5	4.0	7.4	2.4	3.6	1.4	5.0	3.5	1.9	2.2	4.8	3.3	2.6	5.1	6.2	3.1	2.4	2.6	2.1	2.2	1.8	4.4	3.1	1.9	1.5	2.6	1.1	2.2	2.0
PTGER3	EP3	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047808	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 71.2;endometrium 1: 65.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;HAP1: 10.5;HDLM-2: 15.9;HEL: 7.7;T-47d: 36.6"	"Group enriched"	"Detected in some"	7	"breast cancer: 4.1;renal cancer: 9.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	49	"basophil: 22.4"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 22.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain									"HPA010689: AB_1855883"	"unprognostic (1.53e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-4)"	32.5	3.0	3.9	6.8	0.7	0.0	71.2	0.2	1.7	7.8	6.3	0.1	3.0	0.5	65.2	16.6	1.7	4.8	11.3	2.6	0.6	2.0	41.5	0.3	0.6	2.2	0.4	1.4	2.4	10.7	0.0	0.4	0.5	1.6	3.3	1.0	0.1	15.5	3.7	0.5	6.2	1.8	31.9	0.5	0.3	9.1	4.0	0.0	0.0	0.7	3.2	0.7	4.4	5.7	0.0	0.4	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	10.5	0.0	0.0	15.9	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.1	0.0	36.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.0	22.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.2	1.7	0.6	2.0	0.4	1.4	1.6	0.0
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 60.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA012375	Approved				"Secreted to extracellular matrix"	4000000	4000000			"HPA012375: "	"unprognostic (4.37e-2)"	"prognostic unfavourable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	36.4	3.2	2.6	13.1	2.0	0.5	60.8	0.3	3.7	15.5	17.7	2.7	5.1	4.3	20.4	8.9	7.4	9.7	12.9	16.2	2.0	2.6	5.8	6.9	14.3	8.5	1.8	1.4	19.2	2.1	1.5	6.5	18.3	3.6	15.2	5.0	7.6	7.3	6.8	8.4	3.7	8.4	41.0	2.6	13.7	7.8	5.8	1.2	4.3	5.9	4.8	3.4	26.3	20.1	0.5	2.0	0.0	0.0	0.0	1.1	0.1	6.7	2.4	12.7	0.0	36.0	33.1	9.7	40.2	32.0	17.6	19.3	0.0	0.1	0.0	57.8	39.7	1.4	0.0	24.7	22.5	0.1	0.4	0.0	25.2	0.0	35.8	0.1	0.0	36.4	7.3	19.9	15.0	43.3	0.0	0.0	25.0	4.0	1.1	1.3	10.3	9.2	2.2	44.5	0.1	20.7	0.0	0.0	23.5	0.0	13.0	0.0	4.7	0.1	42.0	29.2	14.4	1.1	31.0	0.0	33.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	2.0	0.0	0.1	2.6	2.0	0.3	2.7	2.0	2.6	1.8	1.4	3.6	1.2
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.1;breast: 210.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.3;SK-MEL-30: 6.9;T-47d: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6"	"Group enriched"	"Detected in many"	30	"granulocytes: 60.6;monocytes: 54.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	68.1	3.7	3.8	3.0	11.4	7.5	210.2	2.1	5.5	4.3	10.9	8.7	2.7	0.5	6.4	4.5	7.2	2.4	14.7	29.7	5.3	2.8	7.6	2.5	2.5	4.5	7.6	3.0	2.6	3.7	14.7	3.5	4.4	6.2	4.7	1.2	3.5	4.8	2.7	5.9	6.6	2.0	4.4	8.9	21.5	3.0	2.6	5.2	1.2	11.3	1.8	1.4	4.5	17.5	0.0	1.8	60.6	54.1	0.0	0.1	15.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.8	1.8	2.3	0.0	10.3	1.0	0.0	0.0	0.7	3.3	0.0	2.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	1.9	0.1	6.9	26.2	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	54.1	0.4	0.0	23.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	60.6	0.0	11.1	0.3	0.1	15.0	3.8	11.4	2.1	5.5	5.3	2.8	7.6	3.0	6.2	5.2
REELD1		ENSG00000250673	"Reeler domain containing 1"		4	146214515-146230878	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"breast: 1.3;epididymis: 1.5;skin 1: 1.7"	"Cell line enriched"	"Detected in single"	87	"HDLM-2: 14.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (6.26e-3)"	"unprognostic (1.40e-1)"		"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-6)"	"unprognostic (2.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.13e-2)"	0.1	0.0		0.9		0.4	1.3		0.2	0.4	0.0			0.0	0.0	1.5	0.0	0.2	0.0	0.0			0.1	0.7	0.2	0.2			0.0	0.4	0.0		0.0		0.3	0.0		0.0	0.0	0.5	1.7	0.0	0.0		1.0	0.0	0.1			0.0		0.7	0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2										
RFX8	FLJ42986	ENSG00000196460	"RFX family member 8, lacking RFX DNA binding domain"	Q6ZV50	2	101397361-101474703	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTEC/SVTERT24-B: 15.4;LHCN-M2: 7.3;U-87 MG: 10.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	12	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA059745: AB_2684120"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	2.1	0.6	0.4	0.8	0.7	10.0	7.5	0.2	2.3	0.9	0.5	0.8	1.3	0.4	0.7	1.7	0.7	0.2	1.0	0.8	0.4	0.9	0.6	0.7	0.7	0.9	0.7	1.6	0.7	0.6	1.0	2.2	0.9	1.6	0.5	0.1	0.8	0.9	0.1	0.5	1.4	0.3	0.8	0.8	0.4	0.4	2.6	0.0	7.8	1.5	0.0	0.3	0.6	2.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	2.0	1.4	1.3	1.4	0.0	3.1	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.0	0.0	15.4	0.1	0.0	0.0	0.0	7.3	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.9	2.8	0.0	0.0	0.0	10.1	4.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	2.3	0.4	0.9	0.7	1.6	1.6	0.0
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"Runt related transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 54.3;lymphoid tissue: 58.6"	"Cell line enhanced"	"Detected in many"		"HEL: 65.0;HMC-1: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	11.5	3.2	5.2	14.8	7.3	29.8	54.3	1.0	4.3	12.5	4.7	3.8	4.0	3.8	2.9	7.4	6.5	4.6	12.4	7.6	6.1	2.0	4.2	6.7	17.9	13.9	8.5	1.1	6.5	5.8	1.6	5.5	6.4	6.0	9.9	5.1	3.5	29.8	8.8	14.4	8.3	5.1	6.8	12.3	10.6	12.7	2.9	6.6	58.6	4.6	5.7	14.2	11.0	9.1	3.2	3.4	17.0	3.9	1.3	4.8	2.0	13.0	1.0	0.0	0.1	3.4	4.4	8.6	7.4	7.5	4.1	3.1	0.6	10.0	6.4	0.5	6.5	11.8	0.8	8.8	6.0	9.9	1.0	65.0	2.6	3.0	6.3	7.5	39.2	8.5	5.3	12.5	12.4	2.3	4.4	3.8	8.7	2.8	30.3	11.9	0.6	3.8	30.7	22.8	3.9	5.5	5.2	0.3	0.0	7.6	1.9	2.7	3.9	17.6	9.7	6.8	8.8	10.1	11.1	12.5	5.1	6.1	8.5	16.5	9.9	17.0	3.2	6.3	3.4	1.4	3.3	3.2	3.1	3.2	0.9	3.1	4.8	3.8	3.5	1.3	3.9	3.4	4.0	2.0	5.2	7.3	1.0	4.3	6.1	2.0	8.5	1.1	6.0	6.6
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242210-62244808	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.5;cervix, uterine: 315.2"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.4"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035318	Approved				"Secreted in other tissues"					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favourable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favourable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		1.8	0.4	0.8	0.2	0.6	0.0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0.0	18.4	43.8	0.8	8.5	0.4	1.0	1.2	0.4	1.1	0.2	0.2	0.2	1.0	0.5	1.1	2.9	0.0	1.0	0.6	7.3	1.1	0.0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0.0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.4	0.2	0.0	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.9	0.5	1.2	0.4	1.0	0.5	7.3	0.5
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433053-52445085	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.2;breast: 89.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.4;Hep G2: 6.2;HUVEC TERT2: 6.6;THP-1: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	4400000	4400000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favourable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	46.2	1.6	3.1	2.4	5.0	0.2	89.1	11.5	5.3	3.5	5.4	2.8	1.5	2.1	3.3	3.0	3.5	3.2	4.5	8.0	3.8	3.3	8.8	0.7	30.4	1.2	5.5	2.5	2.0	2.2	1.1	1.1	19.3	3.1	2.9	2.8	6.8	13.6	2.1	8.0	5.2	6.7	3.2	3.6	7.2	2.7	2.0	1.1	0.4	3.5	4.7	1.4	3.7	5.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.1	0.2	23.4	0.2	2.6	0.0	0.0	0.0	0.0	0.7	0.4	3.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.4	0.2	6.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.2	4.0	1.2	0.1	0.0	0.0	3.7	0.0	0.2	0.6	0.6	0.0	0.3	0.4	2.0	5.8	2.5	0.0	2.5	0.0	0.0	0.4	1.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	5.0	11.5	5.3	3.8	3.3	5.5	2.5	3.1	1.1
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26051031	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.3	0.0	0.7	0.0	2.0	0.0	12.9	0.0	0.5	1.5	0.0			0.4	0.0	7.9	0.0	0.0	0.3	0.0	2.0	0.6	3.0	0.0	3.7	0.1	1.1		0.0	0.0	0.0	1.7	0.0		0.4	0.0		1.9	0.0	10.2	1.0	0.3	0.0	3.5	0.0	1.6	0.9			20.8		0.3	0.0	0.0	0.8	0.6	2.2	1.1	1.0	5.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.2	2.6	1.0	0.0	0.0	1.2	0.7	0.0	0.0	13.8	0.7	1.4	0.3	10.0	5.0	0.0	32.0	0.2	1.2	4.5	0.3	0.0	0.2	0.0	3.5	0.4	0.1	1.1	0.0	0.5	20.0	4.3	0.0	0.0	0.0	0.0	0.0	2.7	2.2	0.4	1.7	0.6	0.7	1.0	0.6	1.7	0.7	0.3	0.8	3.9	5.6	1.6	1.0	1.1	0.6	0.7	0.4										
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Group enriched"	"Detected in some"	4	"BJ: 19.1;BJ hTERT+: 8.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.1	8.8	2.9	3.1	0.3	0.3	0.3	0.1	0.4	0.3	0.2	0.0	0.9	0.2	0.1	0.1	1.3	0.1	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.2	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849263	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.3;breast: 15.2;skin 1: 17.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;BJ: 4.8;BJ hTERT+: 3.9;HaCaT: 3.6;HBEC3-KT: 1.6;U-266/84: 2.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016662	Enhanced									"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	20.3	0.5	0.6	0.9	0.7	0.0	15.2	0.1	0.6	3.7	1.6	0.0	2.1	0.1	2.0	0.8	12.5	0.8	1.4	1.2	0.4	0.2	0.2	0.2	1.2	0.1	2.7	0.0	0.4	1.1	0.9	3.7	0.3	0.9	0.9	0.4	0.0	2.0	0.5	2.3	17.7	0.4	2.4	1.6	0.3	0.5	4.9	1.1	0.0	1.4	11.2	2.9	4.6	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.9	0.1	0.2	4.8	3.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	3.6	0.2	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.7	0.1	0.6	0.4	0.2	2.7	0.0	0.9	1.1
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.1	0.4	7.2	0.1	0.2	0.3	0.6	18.4	0.5	0.4	0.2	0.1	0.5	0.5	0.5	0.8	0.1	1.2	0.1	0.9	0.7	1.7	0.2	0.2	3.2	0.4	0.1	0.9	0.0	0.2	0.8	0.0	1.8	0.1	0.6	3.2	0.3	0.3	0.2	0.2	0.2	0.3	1.0	0.1	0.5	2.0	0.5	0.3	0.2	0.5	0.5	0.5	4.1	0.3	0.2	0.1	0.6	1.4	0.3	0.4	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"BEWO: 4.2;HHSteC: 2.5;HSkMC: 3.6;THP-1: 8.2;U-2 OS: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	8.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8
SMIM34B		ENSG00000278961	"Small integral membrane protein 34B"	A8MWV9	21	7784482-7793954	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 4.5;kidney: 16.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;SK-MEL-30: 2.6;U-87 MG: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 3.1;myeloid DC: 1.7"	"Low lineage specificity"	"Detected in many"											HPA029085	Uncertain									"HPA029085: AB_10669867"																		0.0	0.0		0.0		0.0	4.5		0.0	0.0	0.0			0.0	0.0	0.1	0.0	3.7	0.0	0.4			16.1	0.1	0.4	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.5	0.7	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	1.7	3.1	0.6	0.0	0.0	0.4	1.1	0.2	0.2	0.0	0.0	0.0	0.3	0.2	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	2.6	1.2	0.3	0.0	0.0	0.5	0.4	0.0	1.1	0.1	0.0	2.5	0.3	0.1	0.0	0.5	3.1	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4										
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA052824	Uncertain		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.8	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	35.5	0.5	0.0	1.0	0.0	0.8	0.2	0.5	0.9	0.1	0.1	0.1	0.1	0.1	0.3	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.3	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4
SPAAR	"LINC00961, SPAR"	ENSG00000235387	"Small regulatory polypeptide of amino acid response"	A0A1B0GVQ0	9	35909483-35937153	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;breast: 13.7;testis: 16.5"	"Group enriched"	"Detected in some"	13	"HUVEC TERT2: 22.1;TIME: 25.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (3.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.40e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.22e-1)"	12.2	0.6	1.4	0.7	2.4	0.0	13.7	0.3	1.2	0.2	0.9	0.3	0.8	0.3	0.5	0.3	0.6	0.4	0.8	5.6	1.4		3.5	1.3	4.6	0.4	1.4	0.1	0.2	0.5	0.1	0.4	6.9	1.9	0.3	0.4	0.9	0.8	0.5	6.2	0.0	0.6	0.8	1.3	0.4	0.3	16.5	1.4	0.0	1.1	1.2	0.0	0.3	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	22.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.5	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0										
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor, Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"breast: 2.7;intestine: 3.6;liver: 3.5"	"Cell line enriched"	"Detected in single"	6	"SK-BR-3: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"						"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.5	1.4			0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.5	0.0	0.0		0.0	0.1	0.0	0.0	0.5		0.3	3.6		1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526307-21537377	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.3;brain: 14.4;breast: 23.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.7;HBEC3-KT: 7.5;hTERT-HME1: 10.2;U-2 OS: 4.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3"						"Secreted to blood"						"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	34.3	0.0	0.2	0.0	0.3	0.0	23.1	0.1	1.4	0.0	2.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.5	0.4	0.7	7.1	0.7	0.2	0.5	1.5	0.0	0.0	7.8	0.0	0.0	12.7	14.4	0.0	0.0	0.0	6.4	0.0	1.3	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.3	2.7	0.4	0.0	0.1	0.0	0.1	0.6	0.5	0.0	0.0	0.2	1.5	0.0	0.5	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.8	14.7	0.0	0.6	0.2	0.0	0.0	0.0	7.5	0.8	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	3.1	0.4	0.1	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.7	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.8	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	1.5	0.2	0.3	0.1	0.3	0.4	0.7	1.5	0.0	14.4	0.2
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.0;breast: 14.7"	"Group enriched"	"Detected in some"	12	"Hep G2: 9.0;SK-BR-3: 16.1;T-47d: 5.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 7.7;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.3"					"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favourable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.9	1.1	12.8	1.2	19.9	2.2	14.7	7.5	19.3	6.6	0.8	3.5	0.0	1.3	3.8	1.2	1.1	0.8	1.1	1.5	14.1	6.4	2.7	0.9	0.9	1.3	12.8	7.2	1.1	1.1	0.6	0.3	1.0	22.0	2.5	0.8	0.0	8.6	0.8	2.2	2.2	0.9	0.6	7.8	1.1	1.4	1.1	16.6	0.0	3.8	0.0	0.7	1.2	0.3	0.8	0.5	5.3	0.4	1.0	0.6	0.1	0.3	0.1	0.4	0.5	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.5	0.7	9.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.5	0.3	0.4	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.5	0.8	0.3	16.1	0.3	5.1	0.4	0.2	0.6	0.4	0.4	0.1	0.3	0.6	0.3	0.2	0.3	0.7	2.0	0.4	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.1	0.8	0.6	0.6	5.3	1.0	0.3	0.5	0.2	0.1	12.8	19.9	7.5	19.3	14.1	6.4	12.8	7.2	22.0	16.6
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein, X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 278.5;ASC TERT1: 62.2;HSkMC: 93.6;HUVEC TERT2: 57.7"	"Group enriched"	"Detected in all"	6	"glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	56	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	56	"dendritic cells: 10.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	310000	310000				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (3.36e-4)"	56.2	11.9	2.2	8.5	5.0	0.0	82.4	6.6	4.8	14.1	23.1	7.7	10.1	3.1	17.7	35.5	15.1	37.1	23.3	28.9	5.3	2.9	4.1	6.6	14.2	27.7	9.6	1.9	11.6	7.8	1.4	1.5	34.1	13.4	22.1	10.2	4.7	9.5	6.6	9.9	8.7	14.4	27.8	18.9	0.6	13.3	14.9	7.3	0.9	17.8	5.3	5.1	29.6	54.6	0.0	10.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.0	278.5	62.2	0.0	2.5	4.8	0.8	1.4	0.0	0.2	0.0	0.0	5.2	0.1	0.1	2.2	0.7	0.0	0.9	0.0	0.0	0.0	12.5	0.2	0.0	93.6	0.1	8.3	4.2	57.7	0.0	0.0	9.3	0.1	0.0	0.0	0.7	1.8	0.0	3.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	11.6	0.0	0.0	24.8	6.0	3.1	7.8	7.2	0.0	0.0	0.0	17.5	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.1	2.2	5.0	6.6	3.2	5.3	2.9	9.6	1.9	13.4	7.3
SRPX2	SRPUL	ENSG00000102359	"Sushi repeat containing protein, X-linked 2"	O60687	X	100644166-100675788	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.2;breast: 57.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 73.9;ASC TERT1: 31.6;HSkMC: 28.4;HUVEC TERT2: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA038786	Approved				"Secreted to blood"					"HPA038786: AB_10672724"	"unprognostic (4.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.59e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.84e-3)"	"unprognostic (1.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.85e-1)"	60.2	5.2	0.4	8.0	2.4	0.3	57.3	0.9	1.1	10.2	5.7	0.9	3.8	1.6	5.6	8.4	15.4	5.0	4.3	10.9	0.9	0.4	5.0	3.5	10.3	2.2	4.3	1.0	9.9	2.9	0.4	1.3	11.6	2.2	7.7	3.0	2.7	3.9	5.5	6.0	2.6	3.4	6.2	5.0	10.1	3.4	5.6	1.2	0.1	7.1	9.1	5.8	17.4	17.8	0.5	0.5	1.2	0.8	0.3	0.3	0.5	2.9	0.5	0.7	0.0	73.9	31.6	0.0	6.6	4.9	2.0	6.6	0.4	4.6	0.0	0.2	4.0	0.1	0.0	3.8	2.1	0.0	0.0	0.0	0.2	0.7	7.5	0.0	0.2	28.4	0.0	7.1	0.2	20.0	0.0	0.0	7.0	0.0	0.0	0.0	0.8	0.1	0.0	0.6	0.0	2.9	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.6	4.4	3.1	2.8	0.2	0.0	0.0	0.0	5.1	0.0	2.3	1.1	0.7	0.2	0.3	0.8	0.1	0.4	0.2	0.2	0.1	0.5	0.2	0.3	1.2	0.3	0.6	0.5	0.1	0.5	0.4	2.4	0.9	1.1	0.9	0.4	4.3	1.0	2.2	1.2
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314713-173329503	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.5;pancreas: 51.8"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 114.1;T-47d: 108.3;U-138 MG: 44.8"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA045372	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	15000000	15000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA045372: AB_10961040"	"prognostic favourable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavourable (1.76e-6)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.17e-8)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	3.6	0.7	0.3	1.4	0.8	0.2	68.5	0.4	2.4	6.5	2.4	0.1	1.4	0.5	1.6	2.4	3.1	1.3	5.8	17.4	0.9	0.4	1.7	0.6	17.3	0.7	2.4	0.0	2.0	51.8	1.5	1.2	12.1	2.8	3.0	0.6	0.1	0.6	5.7	10.8	7.4	1.7	8.8	7.1	14.8	2.2	0.8	1.0	0.0	4.5	0.7	0.4	9.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	0.3	1.5	5.5	2.3	15.2	26.1	26.0	6.6	12.9	8.3	4.2	0.0	4.0	15.4	2.4	3.8	8.1	11.6	0.0	2.2	0.0	2.8	5.6	34.8	1.8	0.5	5.0	13.0	15.4	1.1	1.8	0.2	0.0	114.1	4.6	0.0	0.0	0.9	8.8	0.0	3.9	3.0	0.0	0.4	4.1	1.1	1.1	0.1	4.5	108.3	1.8	16.6	44.8	0.1	26.1	5.5	5.1	2.7	1.2	8.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	2.4	0.9	0.4	2.4	0.0	2.8	1.0
STH	MAPTIT	ENSG00000256762	Saitohin	Q8IWL8	17	45999250-45999694	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.2;breast: 1.9;placenta: 1.6;skeletal muscle: 2.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;HDLM-2: 3.1;PC-3: 1.0;RT4: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.24e-1)"				"unprognostic (3.22e-1)"													0.0	0.0	0.8	0.0	1.3	0.0	1.9	4.1	4.2	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.9	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.3	1.6		0.2	0.0		0.5	0.0	2.5	0.7	0.0	0.0	0.6	0.0	0.0	0.4			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.9	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150526-144188370	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 68.1;breast: 41.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.0;Karpas-707: 13.6;RH-30: 8.7;TIME: 11.0;U-266/70: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 13.4;granulocytes: 45.5;monocytes: 40.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					19000000	19000000			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	20.0	3.6	0.7	7.0	1.2	68.1	41.9	0.3	0.8	1.4	3.1	0.6	0.0	1.1	1.1	2.2	4.4	2.0	2.4	8.8	1.8	0.9	2.0	5.4	26.3	14.5	1.2	0.0	2.5	0.9	0.6	2.4	15.5	1.8	1.9	1.0	1.6	1.6	0.6	5.3	5.6	2.5	1.9	2.0	20.6	1.4	0.9	1.0	2.8	8.2	4.0	6.8	2.6	6.1	0.8	13.4	45.5	40.8	1.5	4.1	18.9	0.5	0.2	0.0	5.8	0.2	0.2	0.9	0.6	0.5	0.6	1.1	0.2	0.5	0.0	0.6	0.9	0.9	0.1	0.2	0.2	25.0	0.9	3.7	0.7	0.0	1.6	0.9	0.4	0.0	0.0	0.3	0.1	6.2	0.1	13.6	0.8	0.3	0.5	1.1	0.0	0.5	0.0	8.7	0.9	0.0	2.7	0.2	0.0	1.6	0.1	2.6	0.0	4.5	11.0	0.1	1.6	0.4	0.4	16.0	6.1	0.0	0.1	2.8	0.5	9.2	35.0	21.6	3.1	40.2	1.9	0.7	1.4	2.6	13.4	0.8	0.5	1.6	45.5	1.5	40.8	1.4	4.1	18.9	0.7	1.2	0.3	0.8	1.8	0.9	1.2	0.0	1.8	1.0
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 17.6;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	3.0	10.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	22000000	22000000	"Plasma membrane"	"Plasma membrane"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 52.8;lung: 99.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;ASC TERT1: 12.0;HHSteC: 27.4;HSkMC: 12.6;U-87 MG: 8.3;WM-115: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055936: AB_2682975"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.07e-1)"	"prognostic favourable (2.67e-5)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (4.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	24.7	2.0	3.4	1.5	3.9	0.0	52.8	0.7	5.3	5.1	10.5	0.7	8.8	2.7	1.6	16.7	4.6	3.6	4.8	5.8	1.6	2.8	1.2	5.8	99.5	1.5	3.4	0.6	10.1	1.9	0.0	3.3	23.5	2.6	7.4	5.1	2.6	2.2	11.7	7.0	1.3	6.6	5.2	1.4	2.3	10.7	3.9	0.6	0.5	3.8	3.7	1.3	5.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	17.7	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	27.4	0.0	0.0	12.6	0.0	0.8	0.1	0.0	0.5	0.1	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	2.3	0.0	0.5	0.0	0.1	8.3	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.7	1.7	1.6	2.8	3.4	0.6	2.6	0.6
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 13.4;SK-BR-3: 22.8;T-47d: 71.6"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favourable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	6.7	4.5	11.4	6.8	12.0	8.2	65.9	7.0	8.9	16.8	7.7	7.5	9.2	2.0	11.7	6.8	16.3	7.2	11.7	5.9	14.0	4.3	9.8	3.3	6.5	5.9	8.7	8.1	6.8	2.4	9.1	9.7	4.0	10.8	11.7	4.1	4.1	16.0	10.6	4.1	13.5	3.6	12.6	20.6	5.2	4.7	13.2	8.6	1.8	7.2	14.8	9.2	9.6	17.6	1.8	3.1	1.6	8.5	1.8	2.1	1.3	0.8	0.1	1.7	0.0	1.6	6.0	0.1	1.4	3.3	0.9	1.5	0.1	1.4	0.7	0.0	3.6	0.0	6.7	1.2	1.0	0.0	2.0	0.0	2.8	0.0	2.1	0.0	0.0	2.8	1.2	2.5	4.7	0.8	0.3	11.0	1.7	13.4	0.0	0.0	0.3	1.4	0.0	0.0	8.4	1.4	0.0	1.5	1.1	0.7	22.8	0.9	71.6	0.6	0.0	4.0	2.1	1.1	2.7	3.0	0.0	1.2	4.3	0.0	2.6	0.0	8.5	0.0	1.7	3.5	2.0	1.0	2.1	2.0	3.1	1.8	1.9	1.8	1.6	1.8	2.5	1.1	0.8	1.3	11.4	12.0	7.0	8.9	14.0	4.3	8.7	8.1	10.8	8.6
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 9.7;prostate: 20.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;MCF7: 10.5;RT4: 7.3;T-47d: 20.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA069293			Approved	Centrosome				Centrosome	Centrosome	"HPA069293: AB_2686110"	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	0.3	1.3	0.6	0.0	9.7	0.3	0.6	0.2	2.2	0.2	0.0	0.6	0.0	1.3	0.6	0.4	1.0	0.0	0.8	0.9	0.0	7.9	5.6	0.0	0.7	0.4	0.4	0.0	0.0	1.1	0.3	0.1	20.5	0.5	0.0	3.0	1.1	0.0	0.8	1.2	2.5	0.6	0.0	3.8	6.0	0.0	0.0	0.0	0.6	2.3	2.2	4.6	0.6	0.2	0.4	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.4	0.0	2.1	1.2	0.2	0.0	0.0	3.0	0.0	0.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	0.0	0.0	4.0	0.0	0.0	0.0	1.0	7.3	2.2	0.0	0.0	4.0	0.0	20.2	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.3	0.6	0.8	0.9	0.7	0.4	0.1	0.0
TWIST1	"ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST"	ENSG00000122691	"Twist family bHLH transcription factor 1"	Q15672	7	19020991-19117672	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 50.0;placenta: 45.6"	"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 74.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"														"unprognostic (4.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.29e-9)"	"unprognostic (8.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.97e-2)"	19.9	5.1	0.6	2.6	0.6	0.1	50.0	0.4	1.2	4.6	3.3	0.5	1.4	0.2	19.6	4.0	7.0	2.2	7.5	3.3	0.6	0.4	0.7	0.3	0.4	2.8	0.7	1.1	6.2	0.4	0.2	5.3	45.6	1.6	7.6	0.6	2.2	6.4	1.0	3.5	12.0	0.4	11.3	1.0	0.1	4.5	3.6	0.5	0.0	2.8	8.6	5.3	12.6	11.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.4	0.5	2.5	0.0	12.8	5.3	0.0	10.4	4.9	8.1	10.6	0.0	0.0	0.0	1.1	8.6	0.0	1.0	0.8	5.3	2.2	2.8	0.0	1.1	0.0	7.6	2.6	0.0	12.8	2.7	1.6	4.4	0.0	0.0	0.0	8.5	0.0	0.0	0.1	1.0	4.3	0.0	0.0	0.0	0.0	0.0	4.4	74.0	1.7	0.0	2.1	0.2	3.3	0.0	10.0	0.0	7.8	1.7	0.0	0.0	0.0	5.4	0.0	12.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.6	0.4	1.2	0.6	0.4	0.7	1.1	1.6	0.5
VEGFC	VRP	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792727	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 20.1"	"Cell line enhanced"	"Detected in many"		"BJ: 41.2;HBF TERT88: 33.5;hTEC/SVTERT24-B: 33.7;LHCN-M2: 37.2"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	50000	50000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	8.9	2.0	0.5	1.9	2.0	0.0	20.1	1.5	1.9	4.8	4.5	0.7	2.9	0.8	6.2	1.5	5.5	5.1	7.7	5.9	0.8		1.5	1.7	16.0	3.5	0.0	0.1	3.9	0.5	0.6	0.0	11.6	1.6	4.8	1.6	3.4	4.3	2.7	6.2	0.2	1.6	3.8	1.7	2.6	0.4	2.4	0.4	0.3	17.7	3.4	2.3	6.8	9.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.5	0.8	0.5	0.0	7.5	7.5	0.0	41.2	24.9	23.0	18.3	0.0	0.2	0.0	0.0	23.2	1.2	0.3	15.5	33.5	0.0	0.8	0.0	1.1	0.0	4.1	0.0	0.0	8.0	0.7	33.7	23.5	14.1	0.0	0.0	37.2	0.6	0.0	0.0	0.3	13.5	0.0	2.4	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.2	0.0	6.8	24.4	2.6	6.0	11.6	0.0	0.0	0.0	10.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1										
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 72.8"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"				"Plasma membrane"	"Plasma membrane"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	72.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.9;breast: 24.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 20.3;CACO-2: 6.5;CAPAN-2: 9.7;EFO-21: 32.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 6.6"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 6.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050101, HPA063569"	Uncertain		Approved	Centrosome,Cytosol	"Secreted to extracellular matrix"			Cytosol	Cytosol	"HPA050101: AB_2681015, HPA063569: AB_2685044"	"prognostic favourable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	25.9	14.1	0.8	1.6	1.0	0.9	24.1	1.8	0.9	3.4	7.6	1.4	0.7	2.6	1.9	6.0	4.7	3.1	3.4	7.2	0.4	0.4	1.2	8.5	4.8	2.3	0.5	0.1	4.3	7.8	0.5	2.3	6.3	2.2	4.0	1.2	1.0	3.4	1.3	11.1	4.5	7.9	3.1	0.3	3.5	0.7	3.7	0.5	0.3	10.8	5.4	0.7	4.6	10.2	0.0	0.0	0.8	0.1	6.6	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.1	20.3	0.0	0.0	0.0	0.1	6.5	9.7	0.0	32.2	0.0	3.0	0.6	0.0	0.0	2.9	1.1	1.6	0.7	1.2	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	1.6	0.2	0.0	1.2	0.1	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.8	1.0	1.8	0.9	0.4	0.4	0.5	0.1	2.2	0.5
ZBED1	"ALTE, DREF, hDREF, KIAA0785, TRAMP"	ENSG00000214717	"Zinc finger BED-type containing 1"	O96006	X	2486414-2500967	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 63.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077591			Approved	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	Nucleoplasm	"HPA077591: AB_2686847"	"unprognostic (7.66e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.27e-1)"	8.5	10.5	24.8	6.0	30.7	3.1	63.7	24.8	29.0	36.8	8.1	1.7	1.7	10.6	28.9	2.8	6.1	6.4	7.1	43.4	27.3	7.2	39.6	13.6	5.9	6.0	25.1	19.6	28.7	10.4	6.8	27.8	37.5	32.5	6.8	6.4	1.7	7.7	6.3	29.5	9.5	11.2	5.1	30.4	7.9	6.6	3.4	27.1	1.7	5.4	1.7	4.8	5.8	31.4	12.7	13.7	13.0	12.4	5.4	11.5	10.2	5.1	12.9	9.4	10.3	6.0	6.4	42.5	7.3	8.1	4.3	5.0	16.4	4.6	10.2	8.5	9.7	2.4	8.9	7.6	3.2	12.0	11.9	7.6	11.0	13.9	7.9	4.6	15.9	9.4	6.0	4.5	3.4	10.2	9.6	3.4	8.4	3.6	7.7	3.7	23.1	7.6	6.2	9.3	4.8	7.2	10.1	11.2	11.0	6.2	16.8	11.6	4.6	10.0	13.9	9.3	4.9	5.1	7.9	4.1	0.0	16.9	3.8	6.7	5.2	1.8	11.6	9.7	11.5	12.4	10.3	9.4	6.8	6.5	13.7	12.7	6.6	5.4	13.0	5.4	9.3	10.1	6.6	10.2	24.8	30.7	24.8	29.0	27.3	7.2	25.1	19.6	32.5	27.1
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.4;breast: 17.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.4;SK-BR-3: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.8;T-cells: 4.4"									HPA065484	Uncertain									"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"	0.4	0.0	0.0	1.1	0.0	0.2	17.4	0.0	0.0	0.4	0.7			0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.3	0.3	1.0	2.1	0.0		0.1	0.2	0.0	0.2	0.0		0.3	1.1		0.2	0.0	0.0	0.1	2.3	0.0	0.2	3.6	0.2	1.2			0.6		0.2	0.6	0.4	0.8	0.1	2.8	0.2	0.5	4.4	0.8	0.3	0.4	0.7	0.7	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.6	0.9	1.0	0.1	0.0	0.3	0.0	0.0	0.0	2.6	0.3	0.2	1.2	0.8	0.0	0.0	0.5	0.4	1.1	0.1	0.0	0.0	0.6	1.4	0.7	6.4	0.2	0.4	2.2	0.1	0.2	1.2	0.2	0.1	0.7	0.6	0.3	0.4	3.5	0.5	2.1	0.8	0.6	0.3	2.8	0.3	0.3	1.8	0.4	1.4	1.5	0.4	0.3	2.8	0.2	1.3	2.1	0.1	0.6	0.7	1.7	4.2	0.0	0.8	0.9	0.9	0.4	0.5	0.0	0.1	4.4	0.8										
